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Abstract 
 
 Aminoglycoside antibiotics are losing their bactericidal efficacy due to the spread of 
enzymes that catalyze a covalent modification to them.  A common property of many of these 
aminoglycoside modifying enzymes (AGMEs) is the capacity to modify multiple diverse 
aminoglycosides thus conferring resistance to these drugs among several pathogenic bacterial 
species.  To gain a better understanding of the protein-antibiotic interactions responsible for 
resistance and the promiscuous nature of AGMEs, a variety of biophysical techniques including 
nuclear magnetic resonance (NMR), isothermal titration calorimetry (ITC), steady state kinetics, 
intrinsic tryptophan fluorescence, and computational modeling are employed in this work.  
Results and discussion presented herein are divided into two parts.   
In Part I, a detailed thermodynamic and kinetic characterization of the association 
between the aminoglycoside acetyltransferase-(3)-IIIb (AAC) and several antibiotics and/or 
coenzyme(s) provides insight into the global properties of the protein.  AAC is shown to have a 
broad substrate range where antibiotic interaction occurs with a favorable enthalpy and 
unfavorable entropy.  When coenzyme A (the non-catalytic form of the acetyl donor, acetyl 
coenzyme A) is present, enthalpy becomes more favored, entropy more disfavored, and 
antibiotic affinity significantly increases.  AAC shows preference for antibiotics with amine 
groups at the 2′ and 6′ positions and to those possessing four or more pseudo-saccharide rings.  
These and other data lay the foundation for understanding AAC and lead into the next discussion 
wherein the source of promiscuity of AGMEs is explored in Part II. 
 The aminoglycoside phosphotransferase-(3′)-IIIa (APH), a representative from the 
phosphotransferase family of AGMEs, has been well characterized previously.  However, none 
 vi 
 
 
of the data presented to date provides rationale for its promiscuity. In this work, NMR derived 
hydrogen-deuterium exchange experiments reveal that APH maneuvers its entire structure to 
accommodate diverse antibiotics.   Furthermore, presence of an antibiotic creates a more stable 
APH conformation while coenzyme induces an antibiotic dependent increase in the flexibility of 
APH.  For comparison, a computationally derived homology model of AAC predicts that its 
promiscuous nature may be due to a large flexible loop.  Taken together, APH and AAC, two 
structurally and functionally diverse proteins, utilize different aspects of structural flexibility to 
facilitate a broad substrate repertoire that is key to bacterial survival. 
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Introduction 
 
Aminoglycoside antibiotics have been used to treat patients with infections caused by 
both gram positive and gram negative bacteria. These drugs exert their bactericidal effect by 
interacting with the ribosome and interfering with protein translation.  However, pathogens are 
growing increasingly resistant to aminoglycosides due to the presence of enzymes that 
chemically modify the antibiotic.  Aminoglycoside modifying enzymes (AGMEs) are classified 
into three categories named for the moiety they transfer and include phosphotransferases, 
nucleotidyltransferases, and acetyltransferases.  Furthermore, more than forty such enzymes have 
been identified to date with each enzyme modifying a specific site on the antibiotic.  Most 
bacterial species harbor genes coding for more than one of these enzymes thus complicating 
treatment of infection.  
Typical aminoglycoside antibiotics share a common 2-deoxystreptamine ring but are 
otherwise diverse where rings can be hexose or pentose derived and the total number of rings can 
vary from 2 to 5.   Moreover, it has been observed that many of the AGMEs discovered to date 
are capable of modifying a great number of aminoglycosides without much prejudice to 
antibiotic size/structure.   This raises the central question:  How are AGMEs so promiscuous?  
Imbedded within this question is the interest in determining if there is a common method by 
which large substrate profiles are achieved.  The first intuition for explaining such promiscuity 
points to protein flexibility and dynamics.  Across the literature, the role of protein dynamics in 
ligand binding is becoming of increasingly intense interest as it brings our knowledge of 
structure-function relationships to a much deeper level.  The promiscuous nature of the AGME–
antibiotic system is particularly amenable to providing new insight into this field.  Furthermore, 
uncovering the secret of substrate selectivity, regardless of mechanism, may be advantageous in 
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designing new drugs that can serve as inhibitors to AGMEs thus reinstating many 
aminoglycosides as useful therapeutics against infectious disease.   
The interest turns first to the acetyltransferase class of AGMEs.  The aminoglycoside 
acetyltransferase-(3)-IIIb (AAC) will be used as a model since global in vivo studies suggests it 
has a large ligand repertoire.  As the name implies, this protein uses acetyl coenzyme A as a 
cofactor and acetylates antibiotics at the amine located at carbon 3 of the 2-deoxystreptamine 
ring, the common component of typical aminoglycoside antibiotics.  Kinetic and thermodynamic 
characterization of this protein (discussed in Part I, Chapters 1 and 2) established its global 
binding properties.  From these, AAC was found to modify more than 8 different 
aminoglycosides with enthalpically driven binding and an unfavorable entropic contribution to 
yield an overall negative free energy of association.  Those aminoglycosides with a higher 
number of amines (with special preference to those at the 2′ and 6′ carbons) and/or with four-
ringed structures have slightly greater affinity to AAC as determined from kinetic Km values as 
well as dissociation constants derived from isothermal titration calorimetry (ITC), fluorescence 
spectroscopy, and nuclear magnetic resonance (NMR).  The presence of CoASH increases 
antibiotic affinity to AAC 5 to 20 fold.  However, the converse is not true, suggesting that the 
coenzyme may be required to orient the active site for optimal antibiotic binding. 
To begin understanding the dynamic nature of this protein, a 
15
N-
1
H heteronuclear single 
quantum coherence (HSQC) spectrum was taken of AAC in the absence of ligands.  This 
spectrum is well resolved and indicative of a well-defined protein structure.  From this, it was 
initially thought that AAC’s antibiotic promiscuity must be by some mechanism other than 
flexibility.  However, upon close inspection of the spectrum, it was observed that only ~ 70% of 
the expected amino acid signals were present.  This suggested that some parts of the protein may 
 3 
 
 
be sampling a few different conformations at such a rate as to cause the NMR signals to be 
broadened and invisible or that the amino acids are in similar environments resulting in signals at 
the same chemical shifts.  Titration of antibiotic to AAC resulted in the saturable shifting of 
several amide signals as well as disappearance of apo-signals and appearance of new ones.  
When CoASH was titrated into AAC multiple effects were also observed and many of these are 
in common with those perturbed by antibiotic indicating that both CoASH and antibiotic can 
influence several of the same residues.  This supports the hypothesis that CoASH rearranges the 
antibiotic binding site where residues in this area would be affected by both ligands.   
Taken together, the above experiments suggest that there are certain parts of the AAC 
structure that are flexible and may represent a means of antibiotic promiscuity.  In the absence of 
a crystal structure for AAC for visual support of the data, a sequence to structure based 
homology model was computationally derived by using the crystal structure of a template protein 
of > 30% sequence identity and an additional 45% charge similarity where the backbone RMSD 
was less than 1 Å between the template and model.  Here, the antibiotic binding site is shown to 
consist of several large loops while the CoASH site is well structured.  Such loops are common 
among many acetyltransferases and have been attributed to the strikingly similar and conserved 
structural fold in the GCN5 related acetyltransferase superfamily (GNAT).   Members of this 
family have a variety of acetyl acceptor specificities ranging from histones to serotonin to 
antibiotics.  Three other aminoglycoside acetyltransferases, AAC(3) from Bacillus anthracis, 
AAC(3) from Serratia marcescens, and AAC(6′) from Enterococcus faecium have 
crystallographic structures available and all maintain the GNAT core fold as does our homology 
model.  The template protein, Yokd from Bacillus subtilis, is also a GNAT protein and shares 
>53% sequence identity and >72% overall similarity with  AAC(3) from Bacillus anthracis. 
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Circular dichroism experiments also support the model in that only ~ 50% of the protein was 
shown to have defined -helical and -strand content leaving the rest to random coils and turns.  
From this we hypothesize that the broad substrate selectivity of AAC is due to the dynamic 
nature of flexible loops. 
The aminoglycoside phosphotransferase (3′)-IIIa (APH) was taken as a model enzyme 
for the phosphotransferase family of AGMEs as it has been well characterized by our and other 
laboratories and is shown to modify more than 10 different aminoglycosides at the 3′ carbon 
using ATP as a source of phosphate.  Furthermore, x-ray crystal structures are available for APH 
in apo form (absence of ligands), in complex with nucleotide alone, and with different 
aminoglycosides plus nucleotide.  Therefore, it was anticipated that much could be learned about 
the role of dynamics and flexibility of the phosphotransferases using this protein.  NMR is a 
commonly used method to study proteins in solution and was the choice technique to begin 
investigation of APH dynamics.  To this end, APH was uniformly labeled with 
15
N for use in 
15
N-
1
H HSQC experiments where the backbone amide of an individual amino acid produces a 
signal in which the position and intensity is correlated to its electronic environment and its 
dynamics, respectively.  Greater than 80% of amino acid assignments for APH have recently 
been published in Biomolecular NMR Assignments where I am a contributing author.  
In the apo form, the HSQC spectrum of APH is highly overlapped indicative of a protein 
structure sampling many conformations.  From this it is hypothesized that the broad substrate 
selectivity of APH is due to a flexible apo-enzyme.  Addition of antibiotic induces a dramatic 
change in the spectrum in which signals become well resolved.  With resonance assignments in 
hand, it was discovered that each antibiotic affects amino acids both in the active site and in 
distal regions in all parts of the protein.  With the exception of a few binding pocket residues, 
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different antibiotics do not affect the same set of amino acids. In fact, neomycin B and 
kanamycin A spectra differ in > 40 out of the ~250 observable amino acids. These data are 
important because they contrast the previous X-ray crystallography derived structures where 
apo-APH and APH bound to kanamycin A or neomycin B differ by only a slight shift in one 
helix and loop near the active site suggesting binding to antibiotic causes changes only in the 
binding pocket region of the protein.  
From these experiments it is apparent that the dynamics of APH is playing an important 
role in its ability to interact with several different aminoglycosides.  To investigate further, NMR 
detected hydrogen/deuterium exchange, a valuable tool with which to decipher dynamic behavior 
of proteins in solution, was utilized.  In this experiment, 
15
N labeled APH in H2O solvent was 
lyophilized to dryness and re-hydrated in D2O.  Subsequently, a series of sequential HSQC 
experiments were performed at various time points after deuteration.  The principle is simple; 
when the N-H of a given amino acid is exposed to solvent, the hydrogen will exchange for a 
deuteron and the signal for that amide will disappear from the spectrum in a time dependent 
manner.  Those amides buried in the core or hydrogen bonded will exchange more slowly than 
those on the surface.  If the protein in question is dynamic in nature, the movement of the protein 
structure will allow even some of the buried and bonded amide hydrogens to exchange with 
solvent.  This type of protein will have overall quicker exchange rates than one less dynamic.  In 
these experiments, apo-APH was found to exchange every backbone amide proton within a few 
hours after deuterium exposure.  To date, a complete exchange has only been observed for 
unfolded proteins and dramatically emphasizes the dynamic nature of this protein.  In the 
presence of antibiotic, however, ~40% remain protected from exchange for > 90 hours thus 
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supporting our previous data.  Moreover, the extent of protection differs in the presence of 
different antibiotics.   
Data from both AAC and APH proteins provide support for our central hypothesis that 
the broad substrate selectivity of AGMEs is due to flexible structural motifs and furthermore 
indicate that protein movement (dynamics) is important for binding and recognition of 
antibiotics.  Although these two proteins share no sequence identity or structural homology to 
each other, their substrate profiles almost completely overlap and they take advantage of two 
different aspects of protein flexibility.  Where AAC employs a large loop in its antibiotic binding 
site, APH utilizes motions of the entire protein to adhere to differing sizes and structures of 
aminoglycosides that it may encounter.  References for all information provided in this 
introduction are provided in each relative chapter from which they are used. 
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Part I 
 
Properties of Antibiotic and Coenzyme Association with the 
Aminoglycoside Acetyltransferase-(3)-IIIb 
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Chapter 1 
 
Thermodynamic and Kinetic Characterization of Antibiotic 
Association with the Aminoglycoside Acetyltransferase-(3)-IIIb 
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Abstract 
 
The thermodynamic and kinetic properties of interactions of antibiotics with the 
aminoglycoside acetyltransferase (3)-IIIb (AAC) are determined with several experimental 
methods. These data represent the first such characterization of an enzyme that modifies the 2-
deoxystreptamine ring common to all aminoglycoside antibiotics. Antibiotic substrates for AAC 
include kanamycin A, kanamycin B, tobramycin, sisomicin, neomycin B, paromomycin, 
lividomycin A, and ribostamycin. Kinetic studies show that kanamycin group aminoglycosides 
have higher kcat values than members of the neomycin group. Only small aminoglycosides 
without intra-ring constraints show substrate inhibition. Isothermal titration calorimetry (ITC) 
and fluorescence measurements are consistent with a molecular size-dependent stoichiometry 
where binding stoichiometries are 1.5-2.0 for small antibiotics and 1.0 for larger. Antibiotic-
enzyme interaction occurs with a favorable enthalpy (ΔH<0) and a compensating unfavorable 
entropy (TΔS<0). The presence of coenzyme A significantly increases the affinity of the 
antibiotic for AAC. However, the thermodynamic properties of its ternary complexes distinguish 
this enzyme from other aminoglycoside-modifying enzymes (AGMEs). Unlike other AGMEs, 
the enthalpy of binding becomes more favored by 1.7-10.0-fold in the presence of the co-
substrate CoASH, while the entropy becomes 2.0-22.5-fold less favored. The overall free energy 
change is still only 1.0-1.9 kcal/mol from binary to ternary for all antibiotics tested, which is 
similar to those for other aminoglycoside-modifying enzymes. 
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Section A: 
Introduction 
To date, our laboratory has used a variety of biophysical methods to characterize the 
thermodynamic properties of enzyme ligand complexes of a representative from both the 
phosphotransferase and nucleotidyltransferase families, namely, APH (3′)-IIIa and ANT (2′′)-Ia 
(4-9). These enzymes not only catalyze different reactions but also modify rings A and C of 
aminoglycosides (4-9) (Figure 1). This paper introduces the aminoglycoside acetyltransferase 
(3)-IIIb (AAC) and describes the first detailed characterization of an enzyme responsible for 
modifying the 3-N position on the central 2-deoxystreptamine ring (2-DOS) (Figure 1, ring B). 
This specificity heralds special importance since all typical aminoglycosides contain an amine 
substituent at carbon 3 of the 2-DOS ring, and any modification of this site causes the loss of 
antibiotic effectiveness (10). Here, the substrate profiles and general properties of binding to 
aminoglycosides in various binary and ternary complexes using isothermal titration calorimetry 
(ITC) and intrinsic tryptophan fluorescence are outlined.  
 
Section B: 
Experimental Procedures 
Chemicals and Reagents.  Butirosin was the generous gift of D. Baker (The University of 
Tennessee). High-performance Ni-Sepharose resin was purchased from Amersham Biosciences 
(Piscataway, NJ), while IPTG was obtained from Inalco Spa (Milan, Italy). Ion exchange matrix, 
Macro Q, was purchased from Bio-Rad Laboratories (Hercules, CA).  Purified thrombin was 
graciously provided by E. Fernandez (The University of Tennessee). All other aminoglycosides, 
coenzymes, and reagents were purchased at the highest possible purity from Sigma. 
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Figure 1:  Aminoglycoside Structures.  The 2-deoxystreptamine ring (ring B) is 4,6-
disubstituted in the kanamycin class (left) while neomycin class (right) aminoglycosides are 4,5-
disubstituted.  Note that amikacin and butirosin are in the kanamycin and neomycin classes, 
respectively.  The five ringed antibiotic shown is lividomycin A while the structure containing a 
double bond in ring A is sisomicin. 
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Cloning, Overexpression, and Purification of AAC.  Previously in our laboratory, AAC (3)-IIIb 
(henceforth to be called AAC for the sake of simplicity except in cases where clarification 
necessitates) was cloned and purified from inclusion bodies (11). Enzyme isolated in this way, 
however, prevented sufficient concentrations that are required for many biophysical and 
spectroscopic studies. Therefore, the AAC gene was cloned with an N-terminal, six-His tag and 
thrombin cleavage site from the original Pseudomonas aeruginosa plasmid [provided by G. 
Miller (Achaogen) and K. Shaw (formerly of Schering Plough)] (11) and transformed into 
Escherichia coli BL21(DE3) cells for overexpression in a soluble form. E. coli TOP10 cells were 
used for long-term storage of the plasmid.  
Overexpression began by inoculation of 1 mL of Luria broth (LB) containing 0.1 mg/mL 
ampicillin (amp) with an isolated colony grown on LB agar plates (0.1mg/mL amp).  After 
growing for 12 h, the bacteria were transferred to 200 mL of LB with 0.1 mg/mL amp and grown 
for 18-24 h; 35 mL of this culture was then transferred to 800 mL of LB with 0.05 mg/mL amp 
and grown to an optical density of ∼1.0 at 600 nm. AAC expression was then induced by 
addition of IPTG to a final concentration of 1 mM. All steps in the overexpression protocol were 
performed at 37°C. Cells were harvested after induction for 4 h and stored at -80°C. The protein 
was found to remain stable in cells stored at this temperature for more than 12 months. 
For purification, BL21 cells were taken from storage, suspended in lysis buffer [100 mM NaCl, 
20mM imidazole, 200 μM PMSF, and 50 mM Tris-HCl (pH 7.6) at 4°C], and lysed with three 
passes through a French press. Crude lysate was then loaded onto a 1 mL Ni-Sepharose column. 
After extensive column washing using 100 mM NaCl, 20 mM imidazole, and 50 mM Tris-HCl 
(pH 7.6) at 4°C, AAC was eluted with an imidazole gradient from 100 to 350 mM.  AAC 
consistently eluted in fractions containing between 140 and 250 mM imidazole. After this step, 
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SDS-PAGE analysis showed AAC to be >99% pure.  Furthermore, the ratio of the UV 
absorbance at 280 and 260 nm was >1.6, ensuring sufficient freedom from nucleic acids. The 
protein solution was then dialyzed against 100 mM NaCl and 50mM Tris-HCl (pH 7.6) at 4°C to 
remove imidazole and excess salt. To avoid interference from the six-His tag, 200 μL of 
thrombin per 25 mg of AAC was incubated at 25°C for 1 h. The protein solution was then passed 
through a Ni-Sepharose column to remove the free His tag. Cleavage was observed to be >90% 
as most AAC eluted from the Ni
+2
 affinity column during the loading and washing steps. 
Because isoelectric points of AAC and thrombin differ by >3 pH units, ion exchange 
chromatography was utilized to remove the protease. Finally, the AAC solution was dialyzed 
extensively against the appropriate buffer at 50 mM (pH 7.6) at 4°C and 100 mM NaCl. Final 
protein yields were consistently between 15 and 20 mg/L of induced culture. The concentration 
of AAC was determined spectrophotometrically using an ε0.1% (280 nm) of 1.4. 
 
Fluorescence Spectroscopy. The change in intrinsic tryptophan fluorescence intensity was used 
to detect interactions of antibiotics with AAC using a Perkin-Elmer (Boston, MA) model LS 55 
fluorescence spectrometer equipped with a stirred four position cell changer with a 1 cm light 
path. Excitation occurred at 295 nm, while emission was monitored at 345 nm. Sample solutions 
contained 1 μM AAC, 100 mM NaCl, and 50 mM Tris-HCl (pH 7.6) at 25°C. Titrations of 
aminoglycosides were conducted via addition of 1-5 μL of concentrated, serially diluted stocks 
into a sample volume of 2.5 mL to a maximum sample dilution of 2.4%. To obtain dissociation 
constants (KD), the percent change in fluorescence intensity was plotted versus substrate 
concentration and saturation curves were fit to the single-site binding equation: 
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(ΔF / F0) * 100 = [(ΔF / F0) * 100][S] / (KD + [S]) 
 
where (ΔF / F0) * 100 is the percent change in fluorescence intensity and F0 represents the 
fluorescence intensity of the sample prior to addition of substrate. Titrations of antibiotics 
yielded an increase in fluorescence intensity. Aminoglycoside titrations into buffer did not yield 
any change in the fluorescence signal. 
 
Isothermal Titration Calorimetry (ITC).  ITC experiments were performed on a VP-ITC 
microcalorimeter from Microcal, Inc. (Northampton, MA), at 25°C. AAC concentrations were 
between 10 and 40 μM for the maintenance of c values ([binding sites] * association constant) 
within the range of 1-100 for greater accuracy of association constant (KA) measurements. 
Desulfated aminoglycosides (12) were present in the syringe at concentrations ranging from 13 
to 60 times greater than that of AAC in the cell. Substrates were diluted into the final dialysis 
buffer used in enzyme purification, allowing both cell and syringe solutions to contain 100 mM 
NaCl and the appropriate buffer at 50 mM (pH 7.6) at 25°C. In ternary experiments, CoASH was 
included in the cell solution at a first site saturating concentration while the antibiotic was 
titrated from the syringe. Samples were degassed for 10 min prior to being loaded. Titrations of 
ligands into buffer were performed as a control, and the resulting heats of ligand dilution were 
subtracted from the experimental data prior to curve fitting. The pH of each cell and syringe 
solution was checked before and after each experiment, and no change was observed. The 
integrity of AAC was ensured by measurement of the enzymatic activity and concentration 
before and after each experiment. In all cases, the enzymatic activity remained greater than 87% 
of the starting activity at the end of titrations. Thermograms were integrated using Origin 
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software provided by the instrument manufacturer, and the best fits were obtained with one-site 
binding. Since binding of aminoglycosides to the enzyme causes shifts in the pKa values of 
several functional groups, all titrations were performed individually in Tris-HCl, HEPES, and 
PIPES buffers with heats of ionization (ΔHion) of 11.4, 5.02, and 2.74 kcal/mol, respectively, to 
determine the intrinsic enthalpy (ΔHint) as described below. ΔG values were calculated from 
association constants (KA) derived from fitted titration curves using the equation ΔG = -RT 
ln(KA).  TΔS values were then determined from the relationship ΔG = ΔHint - TΔS.  
Data from the three buffers described above were used to construct a plot of the observed 
heat, ΔHobs, versus ΔHion which yields a linear correlation of the equation ΔHobs = (Δn)(ΔHion) + 
ΔHint, where Δn is the net number of protons transferred as a result of ligand binding and ΔHint is 
the intrinsic enthalpy of binding. This equation is the simplified form of the equation ΔHobs = 
ΔHint + Δn[αΔHion + (1- α)ΔHenz] + ΔHbind.  ΔHobs denotes the observed binding enthalpy of 
formation of a complex in a given buffer, where ΔHion describes the heat of ionization of the 
buffer. The term Δn[αΔHion + (1- α)ΔHenz] represents the heat of ionization of groups from the 
ionization of buffer and the protein to maintain pH, where α represents the fraction of 
protonation contributed by the buffer (13). In addition, ΔHbind represents the heat of binding of 
buffer to the enzyme. In the presence of high salt (i.e., 100 mM NaCl), ΔHbind is assumed to be 
zero and the contribution from the ionization of amino acids remains the same at a given pH (i.e., 
is independent of buffer).  Thus, by performing experiments in buffers with different heats of 
ionization, one can easily determine ΔHint and Δn. However, note that ΔHint still includes the heat 
of ionization of groups from protein and ligand that are contributing to Δn which would represent 
the true ΔHint only when Δn = 0. For the buffers used in this work, a net proton uptake by the 
enzyme-ligand complex yields a positive Δn. In the case of binary titrations with kanamycin A, 
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ACES (ΔHion = 7.5 kcal/mol) replaced Tris-HCl because its heat of ionization almost completely 
masked ITC signals for this experiment.  
Titrations of neomycin into the AAC-CoASH complex yielded a dissociation constant in 
the submicromolar range, making the c value >300. Protein concentrations could not be 
decreased to lower the c value because of enzyme instability under dilute conditions. To obtain a 
more accurate dissociation constant (KD) for dissociation of neomycin from the ternary AAC-
CoASH-neomycin complex, we performed the following experiment. The cell was loaded with 
AAC in complex with a first site saturation level of CoASH and enough ribostamycin to saturate 
>95% of the binding sites. Neomycin was loaded into the syringe and subsequently titrated into 
the AAC-CoASH ribostamycin complex. Because the dissociation constants of neomycin and 
ribostamycin differ by 1 order of magnitude, the latter serves as a competitive inhibitor against 
neomycin. From the fit of this titration curve, the apparent dissociation constant [KD(app)] was 
obtained and used to determine the dissociation constant for neomycin. 
 
Steady State Kinetics. Kinetic parameters were determined by a continuous assay using a Cary 
Win UV-vis spectrophotometer (Varian, Palo Alto, CA). The following coupled reaction allowed 
AAC activity to be monitored via the increasing absorbance of pyridine 4-thiolate at 324 nm 
(14): 
 
                                                                              AAC 
AG + AcCoA        AG–C(O)CH3 + CoASH 
 
4-4′-Dipyridyl disulfide + CoASH      CoA-S-S-pyridine + Pyridine-4-thiolate 
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Samples consisted of 100 mM NaCl and 50 mM Tris-HCl (pH 7.6) at 25°C. AAC (10 nM) was 
used in each assay, and the reaction was initiated by addition of aminoglycoside at various 
concentrations while the AcCoA concentration was held at 100 μM. The signal molecule, 4,4′-
dipyridyl disulfide, was present in excess at 750 μM. Reactions followed Michaelis-Menten type 
kinetics with all substrates tested. Since substrate inhibition, as in several aminoglycoside 
modifying enzymes, is observed with AAC, reported kinetic parameters were determined via fits 
of specific activity (micromoles per minute per milligram) versus substrate concentration to the 
equation: 
v =  Vmax[S] / (Km + [S] + [S]
2
/Ki) 
 
 
where v is the initial velocity, Vmax is the maximal velocity, Km is the Michaelis constant, and Ki 
is the substrate inhibition constant. Turnover rates (kcat) were calculated from the relationship 
Vmax = kcat[E]T. 
 
Section C: 
Kinetic Specificity with Aminoglycosides 
Steady state kinetic analysis reveals that tobramycin, kanamycin A, kanamycin B, 
sisomicin, neomycin B, paromomycin A, ribostamycin, and lividomycin (Figure 1) are all 
substrates with measurable rates. Although low micromolar Km values of all tested 
aminoglycosides are within a narrow range (Table 1), catalytic turnover rates (kcat) reveal that the 
kanamycin class aminoglycosides are bound, acetylated, and released more quickly than 
members of the neomycin class (Table 1). While kcat values for kanamycin group 
aminoglycosides are between 46 and 55 s
-1
, the range for members of the neomycin group covers 
values between 10 and 34 s
-1
.   
 19 
 
 
 
 
 
 
 
 
Table 1: Kinetic Parameters for Antibiotics. 
 
Substrate Km (μM) Vmax (μmol/min/mg) kcat (s
-1
) kcat/Km (M
-1
s
-1
) 
a
 Ki (μM) 
Neomycin B 1.2 ± 0.2 18.4 ± 3.4 9.5 ± 1.8 9.1 ± 3.6 > 1500 
Paromomycin 3.3 ± 0.6 65.0 ± 2.7 33.6 ± 1.4 10.8 ± 2.5 > 500 
Ribostamycin 2.3 ± 0.6 45.6 ± 5.3 23.5 ± 2.7 10.6 ± 1.7 59.4 ± 17.2 
Lividomycin A 3.6 ± 0.1 65.5 ± 2.7 33.8 ± 1.4 9.5 ± 0.8 > 600 
Kanamycin A 4.8 ± 0.5 99.4 ± 8.6 51.4 ± 4.4 11.2 ± 2.3 381 ± 95 
Kanamycin B 2.6 ± 1.6 105 ± 7.0 54.5 ± 3.6 34.4 ± 19.8 26.3 ± 18.6 
Tobramycin 1.3 ± 0.8 92.5 ± 9.3 47.8 ± 4.8 60.5 ± 34.6 17.3 ± 5.9 
Sisomicin 1.5 ± 0.4 89.6 ± 4.3 46.3 ± 2.2 33.4 ± 9.5 > 700 
 
 
Data and errors are calculated from the average of two trials with errors as the standard error of 
the mean. 
a
kcat/Km values are 10
6
.  
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To the best of our knowledge, this is the first observation of such discrimination among 
those aminoglycoside-modifying enzymes that can use both kanamycins and neomycins as 
substrates. This suggests that antibiotic orientation in the active site, governed by the 4,5- or 4,6-
substitution pattern on the 2-deoxystreptamine ring (2-DOS) (Figure 1), plays a role in how fast 
AAC is able to function. An interesting observation was that neomycin B exhibited a 
significantly lower kcat even compared to the rest of the neomycin group aminoglycosides. 
Aminoglycosides substituted at the N-1 site (amikacin and butirosin) do not show any 
measurable rates even when a high concentration of enzyme is present. Turnover rates are 
estimated to be less than 7.7 * 10
-4
 and 8.3 * 10
-6
 s
-1
 for amikacin and butirosin, respectively. 
Since these antibiotics can still bind to the enzyme (Table 2), apparently the presence of any 
bulky group at N-1 distorts the orientation of the antibiotic in the active site such that N-3 cannot 
be aligned optimally for acetylation regardless of the substitution pattern of the 2- 
deoxystreptamine ring.  
Specificity constants (kcat/Km) for the reaction catalyzed by AAC are on the order of 10
7
 
M
-1
 s
-1
 for the vast majority of aminoglycosides, a value that ranks among the highest of all 
aminoglycoside modifying enzymes studied to date (21-26). Despite the antibiotic-specific 
differences in Km, kcat compensates in most cases, the result being that all specificity constants 
fall within a narrow range (Table 1). However, those antibiotics in the kanamycin class that have 
a 2′-amine group (tobramycin, kanamycin B, and sisomicin) have higher specificity constants 
than the rest. Like those for many other AGMEs, high concentrations of antibiotics induce 
substrate inhibition of AAC activity.  Ki and Km values are not correlated, meaning that a given 
antibiotic with a low Km does not necessarily exhibit a low Ki.  However, we observed that the 
smaller and/or less structurally constrained aminoglycosides, including kanamycin B,   
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Table 2:  ITC Derived Thermodynamics of Aminoglycoside Binding to AAC. 
 
 
Aminoglycoside N KD (μM) Hint (kcal/mol) –TΔS (kcal/mol) ΔG (kcal/mol) n 
NeoB Bin 1.1 ± .04 0.6 ± 0.1 –16.3 ± 2.1 7.8 ± 1.0 –8.5 ± 0.1 0.6 ± 0.2 
NeoB Tern 1.1 ± 0.1 
b
0.04 ± 0.02 –28.5 ± 3.1 18.5 ± 2.0 –9.9 ± 0.2 0.8 ± 0.2 
Paro Bin 1.0 ± .02 9.2 ± 0.4 –18.4 ± 0.9 11.5 ± 0.6 –6.9 ± 0.04 1.1 ± 0.1 
Paro Tern 0.9 ± .01 1.5 ± 0.3 –32.7 ± 2.6 24.7 ± 2.0 –8.0 ± 0.1 1.9 ± 0.3 
Ribo Bin 1.8 ± 0.1 53.3 ± 5.5 –6.8 ± 0.4 0.9 ± 0.1 –5.8 ± 0.1 0.4 ± .02 
Ribo Tern 0.9 ± 0.1 4.7 ± 0.9 –27.5 ± 0.7 20.2 ± 0.5 –7.3 ± 0.1 1.1 ± 0.4 
KanA Bin 2.7 ± 0.3 79.8 ± 22.9 –1.2 ± 0.4 –4.4 ± 1.3 –5.6 ± 0.2 –0.07 ± 0.07 
KanA Tern 1.7 ± 0.3 16.0 ± 1.4 –12.8 ± 1.3 6.2 ± 0.6 –6.6 ± 0.1 1.3 ± 0.3 
KanB Bin 1.6 ± 0.2 29.5 ± 2.2 –8.1 ± 0.5 1.9 ± 0.1 –6.2 ± 0.04 0.6 ± 0.01 
KanB Tern 1.0 ± 0.8 3.9 ± 0.8 –26.0 ± 0.5 18.6 ± 0.4 –7.4 ± 0.1 1.5 ± 0.03 
Tobr Bin 1.5 ± 0.1 33.4 ± 7.0 –8.4 ± 0.8 2.3 ± 0.2 –6.2 ± 0.1 0.6 ± 0.1 
Tobr Tern 1.1 ± 0.02 2.9 ± 0.6 –22.2 ± 1.7 14.6 ± 1.1 –7.6 ± 0.1 1.0 ± 0.1 
Amik Tern
a
 1.9 ± 0.1 101 ± 4.1 –7.7 ± 0.5 2.2 ± 0.1 –5.5 ± 0.4 ND 
Buti Tern
a
 2.2 ± 0.2 165 ± 15 –5.7 ± 0.7 0.6 ± 0.1 –5.1 ± 0.6 ND 
 
 
Given errors are calculated as the standard error of the mean of two to six trials. Errors in the 
intrinsic enthalpy (Hint) and in net protonation (n) are derived from the deviation from 
linearity of Hobs vs. Hion curves.  “Bin” and “Tern” nomenclature refers to the binary and 
ternary complexes as per the absence or presence of CoASH with AAC, respectively.  
a
These 
experiments were performed only in PIPES buffer, pH 7.6 at 25°C and 100 mM NaCl. 
b
The 
dissociation constant for the neomycin ternary complex was determined via competition with 
ribostamycin as described in experimental procedures.  ND = not determined. 
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ribostamycin, and tobramycin, have significantly stronger inhibition constants than those larger 
than them or those with a more conformationally restricted ring structure (i.e., lividomycin or 
sisomicin, respectively). 
 
Section D: 
Antibiotic Binding 
Binding of several aminoglycosides with a 4,5- and 4,6-disubstituted 2-DOS ring to AAC 
was studied by fluorescence and ITC to determine the thermodynamic properties of AAC-ligand 
complexes.  While ITC studies form the main source of thermodynamic data, dissociation 
constants and stoichiometries of enzyme-ligand complexes determined by fluorescence were in 
excellent agreement with those from ITC.  
Thermodynamic studies of only a select few aminoglycoside modifying enzymes can be 
found in the literature (6-9, 27). Among these, it has been shown that antibiotic binding occurs 
with a favorable enthalpy (ΔH < 0) and a compensating unfavorable entropy (TΔS < 0), yielding 
a net result of a favorable ΔG. The same is true of AAC-aminoglycoside interactions in which 
binding of aminoglycosides to AAC is an exothermic reaction (Figure 2) accompanied by 
negative entropy (Table 2), with the possible exception of kanamycin A where the formation of 
the binary complex occurs with a favorable entropic contribution. We should note, however, that 
the binding of kanamycin A to AAC occurs with a very small heat release (the directly measured 
quantity in ITC) with the weakest binding constant compared to those of all substrates of this 
enzyme. Thus, these data may be more prone to curve fitting errors because of the low signal-to-
noise ratio.  
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Figure 2:  Typical ITC Signals for an Antibiotic Titration into AAC.  (A) A typical 
thermogram (upper panel) and isotherm (lower panel) of an antibiotic titration into AAC. In the 
isotherm, data points are shown with a fitted line to a single site binding.  (B) A titration of the 
same antibiotic into the AAC–CoASH complex illustrating the increase in heat and affinity from 
the significant changes in both x and y axes scales.  
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The general trends of favorable ΔH and unfavorable TΔS for AGME-antibiotic 
associations hold regardless of whether the cofactor(s) is present. However, there is a difference 
between AAC and the other AGMEs.  Data acquired with enzymes that utilize MgATP as a 
cosubstrate, APH (3′)-IIIa and ANT (2′′)-Ia, show that the presence of a metal-ATP analogue at 
saturating concentrations induces a less favorable intrinsic enthalpy and a more favorable 
entropy for antibiotic association relative to those in the absence of the analogue as observed 
with APH (3′)-IIIa (7).  In the case of ANT (2′′)-Ia, some aminoglycosides show the same pattern 
as APH (3′)-IIIa while others have no significant change from binary to ternary (9). For APH 
(3′)-IIIa, this phenomenon is attributed in part to hydrogen bond breakage in a β-sheet as a result 
of nucleotide binding (4). The only other aminoglycoside acetyltransferase with available 
thermodynamic data is the aminoglycoside acetyltransferase (6′)-Iy [AAC (6′)-Iy]. With these, 
enzyme data for both binary and ternary complexes were acquired with only one 
aminoglycoside, lividomycin, and showed that neither ΔH, TΔS, nor ΔG is altered in the 
presence of a cofactor (27). In contrast to these observations, ΔH becomes 1.7-10.0-fold more 
favorable in the presence of CoASH (Figures 2 and 3) while TΔS is 2.0-22.5- fold less favorable 
for binding of aminoglycosides to AAC (Table 2). The net result is a small change in the overall 
free energy (ΔG) for the formation of the ternary complex which becomes more favorable by 
only 1.0-1.9 kcal/mol relative to the binary complex. Among the enzymes with data available, 
AAC is the only one that modifies the 2-DOS ring. Thus, our data suggest that the observed 
difference in thermodynamics of enzyme-ligand complexes is more dependent on the site of 
modification than the type of reaction catalyzed by AGMEs. Data from multiple enzymes are 
needed to confirm this observation.  
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Figure 3:  Intrinsic Enthalpy for Antibiotic Binding to AAC.  The intrinsic enthalpy of 
antibiotic binding is much more favorable in the presence of CoASH.  Here, the solid bars 
represent binary titrations of antibiotic into AAC while striped bars are titrations into the AAC in 
complex with a saturating level of CoASH. 
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The weakened entropic contribution in the titration of the AAC-CoASH complex with 
antibiotics may be due to cofactor stabilization of a particular protein conformational state in 
which certain loops are positioned for optimal aminoglycoside binding. In the absence of 
CoASH, the equilibrium may be shifted toward a conformation in which these regions are more 
disordered. Alternatively, a different number of conformationally restrained water molecules 
may be “released” or “acquired” between the binary AAC-aminoglycoside complex and the 
ternary AAC-CoASH-aminoglycoside complex, which contributes differentially to the overall 
entropy of the system. An increase in favorable enthalpy suggests that either a greater number of 
interactions of aminoglycosides with the enzyme, interactions of ligands with each other, or both 
are contributing to the observed increase in favorable enthalpy (more negative ΔH). The 
presence of both substrates in the active site is likely to be coupled to loop stabilization as 
undoubtedly more interactions would be required in such a conformational state. Such 
hypotheses are supported by the significant (5-20-fold) increase in the affinity of aminoglycoside 
for AAC when the CoASH binding site is saturated as observed in both ITC and fluorescence 
experiments (see below) (Figure 4). Significant affinity enhancements via the coenzyme have 
been observed for other acetyltransferases, including the aminoglycoside acetyltransferase (6′)- 
Iy[AAC(6′)-Iy] (27) and the arylalkylamine-N-acetyltransferase (28), while only slight increases 
have been reported for the nucleotide utilizing enzymes APH (3′)-IIIa and ANT (2′′)-Ia (7, 9).  
These latter two proteins are structurally dissimilar to each other and to the acetyltransferases. 
Again, these observations suggest that thermodynamics of the enzymes that modify the central 2-
DOS ring of aminoglycosides are different from those of other AGMEs. Binding of neomycin, 
paromomycin, and kanamycin A to AAC was also studied by fluorescence spectroscopy.  
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Figure 4:  Fluorescence Spectroscopy for Antibiotic Association with AAC.  (A) Typical 
fluorescence spectrum for antibiotic binding to AAC.  As indicated by the arrow, an increase in 
fluorescence intensity is observed as a result of antibiotic binding.  (B) Effect of CoASH on 
antibiotic binding.  The solid and dashed curves represent one site binding for antibiotic 
interaction with AAC in the presence and absence of the CoASH, respectively. 
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 These studies yield dissociation constants very similar to those determined by ITC for 
neomycin and paromomycin (1.0 ± 0.1 and 22 ± 5 μM, respectively) and an even weaker KD 
(∼120 μM) for kanamycin A, confirming ITC data.  We note that the change in fluorescence 
intensity was 11 - 14% for binding of neomycin and paromomycin but only ∼5% for kanamycin 
A in binary titrations. Data acquired by fluorescence spectroscopy showed that titration of an 
antibiotic into the AAC-CoASH complex results in a 2-10-fold increase in aminoglycoside 
affinity relative to that in the respective binary titration (Figure 4). Data, fit to a single binding 
site, yielded dissociation constants of 0.7 ± 0.2, 3.1 ± 0.5, and 40 ± 4 μM for neomycin, 
paromomycin, and kanamycin A, respectively. These are in excellent agreement with those 
determined by ITC (Table 2).  
Unlike kinetic data where kcat values of neomycins as a group were lower than those of 
kanamycins, there is no thermodynamic parameter that separates kanamycins from neomycins. 
Nor is there any correlation between the kinetic parameters Km, kcat, and kcat/Km and the 
thermodynamic parameters KD, ΔH, TΔS, or ΔG for binding of aminoglycoside to AAC.  
However, recall in kinetic experiments that the degree of substrate inhibition is correlated with 
the size of the antibiotic. ITC experiments show the same size-specific trend in terms of binding 
stoichiometry. Binary enzyme-aminoglycoside complexes with the smaller antibiotics show a 
stoichiometry of 1.5-2 aminoglycoside molecules per enzyme, excluding kanamycin A, which 
yielded a stoichiometry of 2.8 based on data with a low signal-to-noise ratio. All larger 
antibiotics, including the four-ring neomycin and paromomycin as well as lividomycin with five 
rings, maintain N values close to 1 (Table 2).  Attempts to fit the data to a sequential binding 
model did not yield acceptable results.  
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Titration of an antibiotic into an AAC-CoASH complex where only the high-affinity 
CoASH site is filled (described in the next chapter) yields a 5-20-fold increase in antibiotic 
affinity. Furthermore, the binding enthalpy becomes significantly more favorable (Figures 2 and 
3) while the entropic contribution becomes more disfavored. Under these conditions, the 
stoichiometry of binding of all aminoglycosides to the enzyme is 1/1 mol/mol regardless of their 
size, with the exceptions of the very weak binding butirosin, amikacin, and kanamycin A (Table 
2). If the same experiment is performed under conditions where both coenzyme sites are 
saturated, antibiotic affinity decreases slightly while ΔH becomes less favored by 7-17 kcal/mol 
and TΔS more favored by 8-17 kcal/mol relative to the conditions where only the first site is 
saturated. The reduced antibiotic affinity is likely the result of competition with the secondary 
coenzyme molecule. A calculation of the thermodynamic cycle mathematically supports the 
competition. 
These observations suggest several possibilities. First, there may be a conformational 
change in the protein upon coenzyme binding to the first site that prevents more than one 
antibiotic from coming into the active site regardless of size. Another probable situation is that 
CoASH binds to only one of several rapidly interconverting conformations of AAC, whereby the 
CoASH-bound conformation becomes the major species via a shift in equilibrium and has the 
loops in the proper orientation to only allow one antibiotic molecule into the binding pocket. 
Alternatively, the site for the second aminoglycoside may partially overlap with the first CoASH 
binding site, and thus, the binding of the second antibiotic molecule is prevented when CoASH 
has saturated this site. Further experimentation is needed to elucidate the effects of ligands on 
AAC structure and is beyond the scope of this work.  A homology model of AAC is discussed in 
Part II, Chapter 1 and may shed some light on these observations. 
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Section E: 
Role of Antibiotic Functional Groups in Binding to AAC 
Binding of aminoglycosides to AAC causes changes in the pKa values of several 
functional groups both in the binary and in the ternary complexes of all aminoglycosides, with 
the possible exception of kanamycin A in the binary complex, yielding a net protonation with the 
formation of each complex [Δn > 0 (Table 2)]. Determined Δn values varied between 0.4 and 1.9 
for different complexes (Figure 5).  Most of this represents a shift to higher pKa values for amine 
functional groups in enzyme bound aminoglycosides. However, contributions of other groups on 
the enzyme cannot be excluded. Such a situation has already been encountered with APH (3′) 
IIIa where up- and downshifts in pKa values of multiple functional groups both on the ligand and 
on the enzyme coincidentally counter-balanced each other and yielded a net value of ∼0 for Δn 
(5). Thus, data interpretation, purely based on the value of Δn, can be misleading.  
Binding data from both ITC and fluorescence reveal that the possession of an amine at 
the 2′-carbon (Figure 1) is highly favored over a hydroxyl group since kanamycin A shows the 
weakest dissociation constant among the antibiotics that are substrates of this enzyme (Table 2). 
This is consistent with the kinetic data in which the Km for kanamycin A is the highest of all 
antibiotics showing measurable rates. The importance of amine groups for aminoglycoside 
recognition by modifying enzymes has been observed previously (9, 27, 33-35). A preference for 
a 2′-amine occurs with AAC (6′)-Iy (27), APH (3′)-IIIa (7, 33, 34), and ANT (2′′)-Ia (9). 
Moreover, these enzymes and AAC share the preference for 6′-amines over hydroxyls. On the 
basis of the few crystal structures available for AGMEs, these phenomena are likely due to the 
presence of carboxyl side chains of amino acids near the active site. Indeed, the homology model  
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Figure 5:  Determination of Intrinsic Enthalpy of Binding.  The observed enthalpy of binding 
determined in different buffers is plotted against the heat of ionization of the buffer as described 
in the Experimental Procedures. The solid black lines are data from kanamycin B in the absence 
(diamonds) and the presence (open circles) of CoASH.  Dashed lines represent the same 
titrations for paromomycin.  R
2 
values for the linear regressions are > 0.95. 
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(see Part II, chapter 1) has several E/D residues localized on or nearby the putative antibiotic 
binding loop in the conserved GNAT motif B.  Although the presence of an amine group is 
preferred over a hydroxyl at the 6′-site, this is true only for those aminoglycosides that are equal 
in size (i.e., neomycin vs. paromomycin) (Figure 1 and Table 2). There also appears to be a link 
between the size of the antibiotic and its affinity for AAC, which can take precedence over the 
preference for an amine group at the 6′-site. Lividomycin and ribostamycin also possess 6′-
amines (Figure 1) but demonstrate a weaker affinity than neomycin. This suggests that an 
antibiotic too large or too small counteracts the favorable effect of the 6′-amine. The trend also 
holds for kanamycin class aminoglycosides where all have an NH2 group at the 6′-carbon but 
consist of only three pseudo-saccharide rings, causing a relative decrease in affinity as compared 
to those with four rings. Similar comparison, however, to determine whether the size preference 
can also override the preference for an amine group at the 2′-site could not be performed because 
of the unavailability of appropriate aminoglycoside derivatives. 
 
Section F: 
Conclusions 
This work represents the first thermodynamic and kinetic characterization of an 
aminoglycoside acetyltransferase enzyme that modifies the common 2-DOS of aminoglycoside 
antibiotics. Because of this specificity, AAC (3)-IIIb is a protein that is capable of conferring 
resistance against a large repertoire of aminoglycoside antibiotics, making it an important factor 
in understanding antibiotic resistance mechanisms. Thermodynamics of AGME-aminoglycoside 
interactions are paramount to the understanding of the molecular basis of drug-enzyme 
association and form a foundation for a more rational drug design to combat antibiotic resistance.  
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N-1-substituted aminoglycosides have the weakest affinity for AAC and are not 
substrates of this enzyme. AAC shows a preference for amines at 2′- and 6′ -carbons, an 
apparently common property for most AGMEs studied to date.  However, unlike other AGMEs, 
this preference appears to be secondary to the size preference of AAC for aminoglycosides. 
Furthermore, catalysis rates are strongly influenced by the chemical structure of the antibiotic, 
where the neomycin class being 4,5-disubstituted on the 2-DOS ring has a kcat slower than that of 
the kanamycins 4,6-disubstiuted on 2-DOS (Figure 1). Also, small antibiotic substrates have the 
capacity to bind to AAC with a stoichiometry of 1.5-2.0 in the absence of the coenzyme. These 
same antibiotics are the only ones capable of substrate inhibition of AAC activity.  
Aminoglycoside interactions occur with a favorable enthalpy and unfavorable enthalpy 
with an overall negative ΔG. In the presence of coenzyme, the enthalpy becomes 1.7-10.0-fold 
more favorable while the entropy becomes less favorable by 2.0- 22.5-fold and ΔG is only more 
negative in the ternary complex by 1.0-1.9 kcal/mol. The affinity of aminoglycosides also 
increases significantly when the coenzyme is present with AAC. Note that the relationship 
between free energy and affinity is ΔG = -RT ln(KA), and thus, even the largest change in 
affinity, 20-fold, from binary and ternary complexes is accompanied by a 1.9 kcal/mol change in 
free energy. 
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Chapter 2 
Coenzyme A Interactions with the Aminoglycoside 
Acetyltransferase-(3)-IIIb and an Analysis of the Thermodynamics 
of a Ternary System 
 40 
 
 
Disclosure 
 
Part I, chapter 2 is reproduced in part with permission from Adrianne L. Norris and Engin H. 
Serpersu. “Interactions of Coenzyme A with the Aminoglycoside Acetyltransferase (3)-IIIb and 
Thermodynamics of a Ternary System” Biochemistry 2010, 49, 4036–4042.   Copyright 2010 
American Chemical Society. 
. 
 
In this article, Dr. Engin Serpersu is the principal investigator from whom guidance and 
experimental advice was obtained.  All work is therefore my own. 
 41 
 
 
Abstract 
In this work, the binding of coenzyme A (CoASH) to the aminoglycoside acetyltransferase (3)-
IIIb (AAC) is studied by several experimental techniques.  These data represent the first 
thermodynamic and kinetic characterization of cofactor interaction with an enzyme that modifies 
the 2-deoxystreptamine ring (2-DOS) common to all aminoglycoside antibiotics.  Acetyl 
coenzyme A (AcCoA) was the preferred substrate but propionyl- and malonyl-CoA were also 
substrates.  CoASH associates with two different sites on AAC as confirmed by ITC, NMR, and 
fluorescence experiments; one with a high affinity, catalytic site, and a secondary, low affinity 
site that overlaps with the antibiotic binding pocket.  The binding of CoASH to the high affinity 
site occurs with a small, unfavorable enthalpy and favorable entropy. Binding to the second site 
is highly exothermic and is accompanied with an unfavorable entropic contribution. The 
presence of an aminoglycoside alters the binding of CoASH to AAC dramatically such that the 
binding occurs with a favorable enthalpy (H < 0) and unfavorable entropy (TS < 0). This is 
irrespective of which aminoglycoside is the co-substrate and occurs without a significant change 
in the affinity of CoASH to AAC.  Also, antibiotics eliminate binding of CoASH to the second 
site. These data allowed the enthalpies of all six equilibria present in a ternary system (AAC–
Antibiotic–Coenzyme) to be determined for the first time for an aminoglycoside modifying 
enzyme.  NMR experiments also shed light on the dynamic nature of AAC as fast, slow, and 
intermediary exchanges between apo- and coenzyme bound forms were observed.   
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Section A: 
Introduction 
Aminoglycoside (AG) antibiotics comprise a group of clinically used drugs that are 
experiencing an ongoing loss of their ability to fight bacterial infections due to evolving bacterial 
resistance to them.  While several resistance mechanisms have been observed, the most 
prominent is the enzymatic covalent modification of the antibiotic.  More than forty enzymes 
have been isolated that are responsible for aminoglycoside modification from both gram positive 
and gram negative bacteria. The enzymes have been divided into three categories based upon the 
chemical group transferred and include phosphotransferases, nucleotidyltransferases and 
acetyltransferases.  The result of such modifications to an aminoglycoside is a significant 
decrease in affinity for the ribosomal target of the antibiotic; hence, protein translation can occur 
normally in the bacterium (1, 2).   
Although a large number of crystal structures of aminoglycoside-modifying enzymes 
(AGMEs) that catalyze acetylation, nucleotidylation, or phosphorylation of aminoglycosides are 
available (3-9), thermodynamic studies of these enzymes are quite limited (10-15). Furthermore, 
there is no data available on an enzyme that modifies the central 2-deoxystreptamine (2-DOS) 
ring of aminoglycoside antibiotics (10-14, 16). We have presented the kinetic and 
thermodynamic properties of the aminoglycoside acetyltransferase (3)-IIIb (AAC) and its 
interactions with antibiotic substrates in the previous chapter.  In this chapter, we describe the 
thermodynamic and kinetic properties of AAC –coenzyme complexes determined by a variety of 
biophysical methods including ITC, fluorescence and NMR.  Because AAC does not require 
metals for efficient binding and catalysis of substrates, as observed with the nucleotide utilizing 
enzymes, these data provide the complementary information necessary to thermodynamically 
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quantify all six equilibria associated with the AAC–coenzyme–antibiotic ternary system (17, 18). 
This is the first such analysis for any aminoglycoside modifying enzyme.  Moreover, these data 
complete the first kinetic and thermodynamic characterization of an enzyme that modifies the 
common 2-deoxystreptamine ring of aminoglycosides.  
 
Section B: 
Experimental Procedures 
Chemicals and Reagents.  Ion exchange matrix (Macro Q) was purchased from Bio-Rad 
Laboratories (Hercules, CA) while high performance Ni-Sepharose resin was purchased from 
Amersham Biosciences, (Piscataway, NJ).  IPTG was obtained through Inalco Spa (Milano, 
Italy) and purified thrombin was graciously provided by Dr. Elias Fernandez, University of 
Tennessee.  All other aminoglycosides, coenzymes and reagents were purchased in the highest 
possible purity from Sigma. 
 
Overexpression and Purification of AAC.  AAC, recovered from inclusion bodies and used in 
previous work (19) was re-cloned with 6X histag and overexpressed in E. coli BL21 (DE3) cells 
in a soluble form.  Purification and removal of histag was performed as described in the Part I, 
Chapter 1.  Briefly, cells were serially grown to 4 liters in Luria Broth and induced for four hours 
with IPTG prior to harvest and storage at -80°C.  Purification of the 6x-Histag AAC was 
performed with a Ni-Sepharose affinity resin and the Histag subsequently cleaved.  Free Histag 
and thrombin used for tag cleavage were separated from AAC by nickel affinity and anion 
exchange chromatography, respectively. 
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Fluorescence Spectroscopy.  The change in intrinsic tryptophan fluorescence intensity was used 
to detect AAC–coenzyme A (CoASH) interactions.  A Perkin-Elmer (Boston, MA) model LS 55 
fluorescence spectrometer equipped with a stirred 4 position cell changer with a 1 cm light path 
was used.  The excitation wavelength was 295 nm for tryptophan selection while emission was 
measured at 345 nm.  Sample solutions contained 1 μM AAC, 100 mM NaCl, and 50 mM Tris-
HCl pH 7.6 at 25°C.  1-5 μL of concentrated, serially diluted CoASH stocks were titrated into a 
sample volume of 2.5 mL.  The maximum sample dilution was 2.4%.  To obtain dissociation 
constants (KD), percent change in fluorescence intensity was plotted versus substrate 
concentration and saturation curves were fit to the single site binding equation: 
            
[(F / F0) * 100] = [(F / F0) * 100][S] / (KD + [S])] 
 
where F/F0*100 is the percent change in fluorescence intensity and F0 represents the 
fluorescence intensity of the sample prior to addition of substrate.  Titrations of coenzyme 
yielded an increase in fluorescence intensity while identical additions into buffer alone showed 
no change in fluorescence signals.   
 
Isothermal Titration Calorimetry (ITC).  ITC experiments were performed on a VP-ITC 
microcalorimeter from Microcal, Inc. (Northampton, MA) at 25°C.  AAC concentrations were 
between 10 and 20 μM in order to maintain c-values ([binding sites]*association constant) within 
the range of 1-100 for greater accuracy of association constant (KA) measurements.    CoASH 
was diluted into the final dialysis buffer used in enzyme purification and was present in the 
syringe at concentrations ranging from 20-40 times greater than that of AAC in the cell.  Both 
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cell and syringe solutions contained 100 mM NaCl and 50 mM of appropriate buffer, pH 7.6 at 
25°C.  In ternary experiments, antibiotic was included in the cell solution at a saturating 
concentration while CoASH was titrated from the syringe.  Samples were degassed for 10 
minutes prior to loading.  Titrations of ligands into buffer were performed as a control and the 
resulting heats of ligand dilution were subtracted from the experimental data prior to curve 
fitting.  Both pH and activity were monitored before and after each experiment. In all cases, the 
enzymatic activity remained greater than 87% of the starting activity and the pH unaltered at the 
end of titrations. Thermograms were integrated using Origin software provided by the instrument 
manufacturer.  Formation of the binary enzyme–CoASH complex was fit to a sequential binding 
model.  For ternary complexes, the best fits were obtained with one site binding. Since binding 
of ligands to the enzyme causes shifts in the pKa values of several functional groups, all titrations 
were performed individually in Tris-HCl, HEPES, and PIPES buffers with heats of ionization 
(Hion) of 11.4, 5.02, and 2.74 kcal/mol, respectively, to determine the intrinsic enthalpy as 
described previously (10, 12, 14, 20). G values were calculated from association constants (KA) 
derived from fitted titration curves using the equation, G = -RT ln(KA).  TΔS values were then 
determined from the relationship ΔG = ΔHint – TΔS.   
 Binding of aminoglycoside to CoASH was also determined with ITC.  Here, 50x 
antibiotic was titrated into CoASH at 800 μM.  Both cell and syringe solutions contained 50 mM 
of the appropriate buffer (pH 7.6 at 25°C) and 100 mM NaCl. 
 
Steady State Kinetics.  To obtain steady state kinetic information, a Cary-Win UV-Vis 
spectrophotometer (Varian, Palo Alto, CA) was used to monitor AAC activity via a continuous 
assay. This assay uses a coupled chemical reaction where an increase in absorbance of pyridine-
 46 
 
 
4-thiolate at 324 nm indicates turnover as described earlier (19, 21).  Samples consisted of 100 
mM NaCl, 50 mM Tris-HCl, pH 7.6 at 25°C.  10 nM AAC was used in each assay and the 
reaction was initiated by addition of aminoglycoside to a final concentration of 100 μM.  
Reactions followed Michaelis-Menten type kinetics with all substrates tested.  Reported kinetic 
parameters were determined via fits of specific activity (μmol/min/mg) vs. coenzyme 
concentration to Michaelis-Menten equation.  Turnover rates (kcat) were calculated from the 
relationship, Vmax = kcat[E]T.   
 
Nuclear Magnetic Resonance.  Nuclear magnetic resonance (NMR) spectroscopy experiments 
were performed using a 600 MHz, Varian Inova Spectrometer equipped with a 
2
H, 
13
C, 
15
N triple 
resonance cryogenic probe at the University of Tennessee.  230 μM of uniformly labeled 15N 
AAC in 100 mM NaCl, 50 mM Tris-HCl, pH 7.6 at 25°C was titrated with 1-3 μL increments 
from concentrated stocks of CoASH.  Sensitivity enhanced  
1
H-
15
N HSQC (heteronuclear single 
quantum coherence) correlation spectra (22) were acquired with 64-128 scans of 64 increments 
in the 
15
N dimension with the TROSY (23) option and a delay of 1.5 s between scans.  2048 data 
points were collected with an acquisition time of 128 ms.  Data were processed with NMRpipe 
(24).  FID was multiplied with sin
2
 window function in the acquisition dimension before fourier 
transformation. No baseline correction or other cosmetic procedures were applied. Spectra were 
exported to Sparky (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San 
Francisco) for analysis and display.  
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Section C: 
Kinetic Selectivity of the Coenzyme  
Steady state kinetic analysis reveals that several coenzyme molecules can serve as 
substrates with acetyl coenzyme A (AcCoA) being the most preferred.  The Km of AcCoA is ~17 
μM and is irrespective of which antibiotic is present as the co-substrate (Table 3).  Propionyl 
CoA and malonyl CoA were both found to be catalytically utilized albeit with 4-10 fold larger 
Km values than AcCoA and specificity constants of 1.5 – 2 orders of magnitude lower.  For all 
parameters, malonyl CoA was the least favored.  This is similar to AAC(6′)-Iy (16) and suggests 
that bulky substitutions at the reactive sulfur hinder coenzyme binding and/or distort the 
alignment of the bound ligand  causing a  decrease in the reaction rate relative to acetyl CoA. 
 
Section D: 
Coenzyme A Binding 
Unlike aminoglycosides, binding of CoASH to AAC shows a biphasic pattern where an 
endothermic, high affinity binding to the first site is followed by a low affinity, exothermic 
binding to a second site (Figure 6A). In the experiment shown in Figure 6A, data fit to a two site 
sequential binding equation which produced an order of magnitude difference in affinity.  
Because of the high error of this fit and non-saturation of the second site, we performed a second 
experiment in which the first site was saturated with CoASH prior to titration of more CoASH to 
obtain a reliable, saturated curve for deriving second site thermodynamic parameters.  In this 
experiment (conducted in two individual buffers), data fit best to a single site model with a 
stoichiometry of 2.9 ± 0.2, indicating a secondary, less specific interaction where the KD is 48.2 
± 1.2 μM, ∆Hint is -3.7 ± 0.1 and T∆S is 9.6 ± 0.3 hence making ∆G to be -5.9 ± 0.2 kcal/mol.   
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Table 3: Kinetic Parameters of Various Coenzymes 
Substrate Km (μM) Vmax (μmol/min/mg) kcat (s
-1
) kcat/Km (M
-1
s
-1
)
b
 
AcCoA (K) 15.4 ± 0.4 76.2 ± 0.9 39.4 ± 0.4 2.6 ± 0.1 
AcCoA (N) 17.0 ± 2.1 20.3 ± 0.2 10.5 ± 0.1 0.6 ± 0.1 
n-Prop. CoA (K)
a
 88.6 ± 20.5 19.8 ± 1.4 10.2 ± 0.7 0.12 ± 0.03 
Mal. CoA (K)
a
 234 ± 62 11.1 ± 1.1 5.7 ± 0.5 0.03 ± 0.01 
 
a
Data and errors for the n-propionyl CoA and malonyl CoA are from curve fitting of Michaelis-Menten 
plots. All others are calculated from the average of two trials with errors as the standard error of the mean. 
b
kcat/Km values are 10
6
. K and N parenthetical notations represent kanamycin A and neomycin B, 
respectively, as the antibiotic held constant in the experiment. 
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Figure 6:  Binding of Coenzyme A to AAC as Detected by ITC.  Thermograms (upper panels) 
representing the titration of AAC with CoASH are shown with fitted data in isotherms (lower 
panels). Lines represent fits to data as described in text. (A) The biphasic nature of CoASH 
binding to AAC alone demonstrates a two site interaction.  (B) CoASH titrated into an AAC–
antibiotic complex yields a monophasic curve with a much greater heat signal. 
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 These values were consistent with the trend observed in the higher error, sequential fit for the 
second site afore mentioned.  Attempts to selectively saturate the first site by limiting the 
concentration of CoASH in the titration syringe were unsuccessful due to the low amount of heat 
associated with this interaction, even in the presence of a high AAC concentration.  However, 
CoASH interaction with AAC was also monitored via intrinsic tryptophan fluorescence and 
NMR spectroscopy (see discussion below).  In both cases, >90% saturation of the first site was 
determined to occur at an enzyme to ligand ratio of ~ 3:1.   With this information, the data points 
in the experiment of Figure 6A higher than 3:1 were eliminated thus allowing analysis of only 
the first site. These data fit to a single site model where the stoichiometry was 0.91 ± 0.08, KD 
=1.9 ± 1.2 µM,  ∆Hobs of 0.4 ± 0.1, T∆S of 8.2 ± 2.1, and ∆G -7.8 ± 2.0 kcal/mol. The 
dissociation constant determined in this manner agreed well with those determined by 
fluorescence and NMR. We also calculated the expected heat of first site CoASH interaction 
from independent experiments and confirmed the low heat experimentally observed (discussed in 
the next section of this chapter).  At this point, we wish to emphasize that the reproducible 
observation of two distinct binding modes itself is more important than the absolute values 
associated with them.  Two thermodynamically distinct modes of CoASH binding was also 
observed with phosphopantetheine adenylyltransferase (25); thus ours is not an orphan 
phenomenon. 
In the presence of aminoglycosides (Figure 7), the thermograms are dramatically altered 
(Figure 6) and binding of CoASH to AAC becomes highly exothermic without a significant 
change in the dissociation constant of the high affinity site. In individual experiments, six 
different aminoglycosides were added to AAC at a saturating level as the co-substrate.  Titration 
of CoASH to AAC–aminoglycoside complexes yields KD values that range between 2.0 and 3.6  
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Figure 7:  Aminoglycoside Structures.  The 2-deoxystreptamine ring (ring B) is 4,6-
disubstituted in the kanamycin class (left) while neomycin class (right) aminoglycosides are 4,5-
disubstituted. 
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μM excluding the weaker binding kanamycin A (Table 4). Enthalpy, entropy and free energy 
values are also antibiotic independent where Hint ranges from -16.7 to -20.8 kcal/mol, TS from 
-9.0 to -11.9 kcal/mol (excluding kanamycin A) and G from -7.1 to -7.8 kcal/mol (Table 4).  
There is no indication of binding to a second site as all stoichiometries to the enzyme are 1/1 
mol/mol and the best fits to the data are obtained with a single site binding model regardless of 
the aminoglycoside present.  These observations suggest that the secondary CoASH interacts 
with the aminoglycoside site with a low affinity that is eliminated by the presence of 
aminoglycoside.  This coincides well with the homology model (discussed in Part II, Chapter 1) 
where several lysine and arginine residues are in the vicinity of the putative antibiotic pocket.  
This could serve as a basis for the secondary coenzyme molecule interaction as CoASH contains 
three highly negative phosphate moieties.   
Initial fluorescence experiments also revealed a biphasic curve for CoASH titration to 
AAC, albeit the transition is more subtle than in ITC (figure 8).  Nevertheless, multiple trials 
reproduced identical results and increased confidence that the transition was indeed real.  To 
more accurately determine dissociation constants, the experiments were repeated with more 
points placed in the lower CoASH concentration range (data not shown).  These trials showed 
that the signal intensity change for selectively binding to the first site is small (4-6%) and yields 
a KD of 3.8 ± 1.3 μM.  For the second site, the dissociation constant is 47.8 ± 2.5 μM and has an 
intensity increase of 12-15%.  No further change is observed in fluorescence intensity upon 
addition of antibiotics to AAC when the CoASH concentration is sufficiently high to saturate 
both sites.  In conjunction with ITC, these data also suggest that a second coenzyme molecule 
may interact with the antibiotic binding site where the tryptophan signals are altered to a similar  
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Table 4:  Thermodynamic Parameters for Coenzyme A Binding to AAC–Antibiotic 
Complexes 
 
Co-substrate N KD (μM) Hint (kcal/mol) –TΔS (kcal/mol) ΔG (kcal/mol) n 
Neomycin B 1.2 ± 0.1 3.6 ± 1.4 –17.0 ± 3.2 9.5 ± 1.8 –7.5 ± 0.3 0.6 ± 0.1 
Paromomycin 1.0 ± 0.02 2.6 ± 1.1 –18.6 ± 0.2 10.9 ± 0.1 –7.7 ± 0.3 1.2 ± 0.02 
Ribostamycin 1.3 ± 0.1 2.5 ± 0.3 –19.0 ± 0.8 11.3 ± 0.5 –7.7 ± 0.1 0.7 ± 0.02 
Kanamycin A 1.1 ± 0.1 6.6 ± 1.5 –20.8 ± 1.6 13.6 ± 1.1 –7.1 ± 0.1 1.4 ± 0.3 
Kanamycin B 1.1 ± 0.1 2.0 ± 0.5 –19.8 ± 0.1 11.9 ± 0.2 –7.8 ± 0.1 0.8 ± 0.1 
Tobramycin 1.2 ± 0.1 2.5 ± 0.7 –16.7 ± 0.2 9.0 ± 0.2 –7.7 ± 0.1 0.6 ± 0.01 
 
Given errors are calculated as the standard error of the mean of two to six trials.  Errors in the 
intrinsic enthalpy (Hint) and the net protonation (n) are derived from the deviation from 
linearity of Hobs vs. Hion curves.  
  
 54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8:  Fluorescence titration of CoASH to AAC.  Change in intrinsic fluorescence 
intensity as a function of added CoASH to AAC. The biphasic nature is more subtle here than in 
ITC but was reproduced in three separate trials.  For clarity only two are shown in triangles and 
open squares with arrows illustrating the transition points. 
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extent as antibiotic.  Indeed, addition of elevated CoASH to the apo-enzyme invoked a large 
intensity change similar to that observed for antibiotic alone (Part I, Chapter 1).  The AAC 
homology model (discussed in Part II, Chapter 1) supports these findings in that the closest 
tryptophan to the coenzyme site is 11.4 Ǻ away and is the same one that is positioned directly in 
the antibiotic pocket.  Thus, it is expected that the coenzyme, being further from this residue, can 
only induce small changes in fluorescence intensity while antibiotic creates large changes.    
A series of 
1
H-
15
N heteronuclear single quantum correlation (HSQC) NMR spectra 
provide structural support the two-site coenzyme model where two distinct sets of spectral 
changes were observed upon CoASH titration. These spectra yielded > 200 observable peaks for 
this 29 kDa protein (Figure 9). Incremental addition of CoASH to 
15
N-enriched AAC causes a 
small number of peaks (~20) to shift until the first CoASH binding site is saturated.  A 
dissociation constant of 1.5 ± 0.5 μM was determined for the binding of CoASH to AAC to this 
site. Upon further titration, several different peaks appear in the spectrum and increase in 
intensity to the saturation of the second site but do not shift.   
Overall, ITC, NMR, and fluorescence yield similar results although dissociation 
constants vary slightly depending on the method of the measurement for the complexes of 
CoASH with the enzyme in the absence and presence of aminoglycosides.  These discrepancies 
are most likely due to the use of a wide range of enzyme concentrations, which covered a span of 
two orders of magnitude, required for each technique as described in the experimental 
procedures section.   
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Figure 9:  
1
H-
15
N HSQC Correlation Spectrum of AAC.   
1
H-
15
N HSQC spectrum of 230 μM 
apo–AAC in Tris-HCl, pH 7.6 at 25°C. 64 scans with 2048 data points are acquired. 
 57 
 
 
Section E: 
Thermodynamic Analysis of a Ternary System  
The thermodynamics of a ternary system (enzyme + ligand1 + ligand2)  are described by six 
equilibria (17) (figure 10).  For the first time for any aminoglycoside-modifying enzyme, this 
work has allowed us to determine thermodynamic parameters of all relevant complexes. Since 
enthalpy is a state property, one can calculate the overall heat of formation of the ternary 
complex, AAC–CoASH– NeoB, from different pathways as shown below:  
 
Pathway 1:  
   AAC + NeoB         AAC–NeoB 
+ 
   AAC–NeoB + CoASH          AAC–NeoB–CoASH 
 
AAC + NeoB + CoASH          AAC–NeoB–CoASH 
 
H1 = -8.3 ± 0.4 kcal/mol 
             + 
H2 = -10.5 ± 0.1 kcal/mol 
 
H3 = -18.8 ± 0.9 kcal/mol 
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Figure 10: The Six Equilibria of a Ternary System   
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Pathway 2:  
   AAC + CoASH          AAC–CoASH 
+ 
   AAC–CoASH + NeoB          AAC–NeoB–CoASH 
 
AAC + NeoB + CoASH          AAC–NeoB–CoASH 
 
H4 = +0.4 ± 0.1 kcal/mol 
             + 
H5 = -18.6 ± 0.2 kcal/mol 
 
H6 = -18.2 ± 2.4 kcal/mol 
 
∆H3 and ∆H6 are identical within error and are calculated from individual, independent 
experiments. Thus, it is reasonable to conclude that the average of these numbers,-18.5 kcal/mol, 
represents the heat of formation of the AAC–NeoB–Coenzyme complex.  Applying this rationale 
to the other aminoglycosides, one calculates the overall heat of formation for the  ternary system  
as -9.7 ± 0.7, -14.4 ± 0.2, -8.8 ± 0.8, -10.7 ± 1.0, and -5.3 ± 2.1 kcal/mol for paromomycin, 
ribostamycin, kanamycin B, tobramycin, and kanamycin A, respectively.  These values are 
averages of H3 and H6 for each aminoglycoside with errors being the deviation of each of 
these enthalpies from the average.   
In these calculations, we used ΔHobs, instead of ΔHint, determined in the same buffer for 
all complexes because ΔHint for the binary AAC–CoASH complex could not be determined 
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experimentally. This was due to the fact that enthalpy of CoASH binding to the high affinity site 
is very low and easily masked by the large enthalpy of binding to the second site in experiments 
performed with several different buffers.  The small heat of interaction can be validated by 
utilizing the additive property of thermodynamic parameters as above.  Consider the following 
equilibria and their experimentally determined enthalpies using neomycin B as the 
aminoglycoside substrate.   
 
   AAC–NeoB–CoASH         AAC–NeoB + CoASH 
+ 
   AAC–CoASH + NeoB          AAC–NeoB–CoASH 
+ 
   AAC–NeoB            AAC + NeoB          
 
  AAC–CoASH           AAC + CoASH 
 
H2 = +10.5 ± 0.1 kcal/mol 
             + 
H5 = -18.6 ± 0.2 kcal/mol 
             + 
H1 = +8.3 ± 0.4 kcal/mol 
 
H4(calc) = +0.2 ± 0.1 kcal/mol 
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This calculated value is virtually within error of the experimentally determined one and 
demonstrates that the heat contribution from CoASH interaction with AAC will be small.  
Similar analyses with different antibiotics yield heats of dissociation between -0.7 and +1.7 
kcal/mol with the exception of kanamycin A.   
Using the same thermodynamic relationship as above with ΔHint values shown in Table 4 
to calculate a theoretical ΔHint for the formation of the binary AAC–CoASH complex, a range of 
values between -1.9 and -5.3 kcal/mol (average -3.7 ±  0.7 kcal/mol) were obtained when data 
for neomycin, paromomycin, kanamycin B, and tobramycin are used separately (the two weakest 
binding aminoglycosides, ribostamycin and kanamycin A, are omitted). These values are also 
close to those determined in a single buffer (ΔHobs) and indicate that there is a small contribution 
of heat of ionization due to small shifts in pKas of functional groups.  It should also be noted that 
CoASH and not AcCoA was used in all experiments in order to prevent catalysis but that AcCoA 
binary titrations yielded similar results to that of CoASH. 
Another experimentally unattainable heat of binding representing the binding of the 
binary CoASH–AG complex to AAC was calculated by using the experimentally-determined 
enthalpy for the formation of CoASH–NeoB complex (Figure 11) with the calculated overall 
enthalpy for the ternary AAC–CoASH–NeoB complex as shown below. Thus, enthalpy of the 
formation of all complexes involved in the ternary system of the enzyme and both ligands 
(CoASH and aminoglycosides) are determined. 
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Figure 11:  Formation of the CoASH–Neomycin Complex.  Titration of neomycin into a 
solution of CoASH yields a saturable curve with an endothermic heat signature as detected by 
ITC.  The thermogram (upper panel) and isotherm (lower panel) are shown. Data fit to a single 
site binding, as described in experimental procedures, is shown as solid line in the isothermic. 
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   AAC + CoASH + NeoB         AAC–CoASH–NeoB 
+ 
   NeoB–CoASH          NeoB + CoASH 
 
AAC + NeoB–CoASH           AAC–NeoB–CoASH 
 
H3 = -18.8 ± 0.4 kcal/mol 
             + 
H8 = - 0.8 ± 0.1 kcal/mol 
 
H7 = -19.6 ± 2.3 kcal/mol 
 
Section F: 
Conclusions 
This work represents the characterization of an aminoglycoside acetyltransferase enzyme 
and its interactions with coenzymes. Here we have shown that AcCoA is the preferred substrate 
where its affinity is irrespective of which aminoglycoside is present as the co-substrate.  Both 
malonyl and propionyl CoA can also provide catalysis although the affinities and turnover rates 
are significantly weaker than AcCoA.   
ITC, fluorescence and NMR studies showed that the coenzyme binds to both a high 
affinity and low affinity site, the latter of which interferes with aminoglycoside interaction as the 
presence of antibiotic reduces the stoichiometry from  2 to a perfect 1 to 1 mol/mol ratio. 
Furthermore, binding to the first site is associated with a low heat signature.  In the presence of 
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antibiotic, however, the heat of CoASH interaction increases significantly without a significant 
change in affinity to the first site and all thermodynamic parameters, KD, Hint, TS, and G are 
irrespective of the antibiotic co-substrate. 
To our knowledge, this paper also presents the first calculation of the heat of formation of 
all six complexes involved a ternary system.  Experimental data from two separate pathways to 
form the ternary complex confirm each other and allow determination of enthalpies that are not 
accessible by experimental means.  All aminoglycosides tested, with the exception of the weakly 
binding kanamycin A, also confirmed the data in an aminoglycoside-independent manner. 
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Deciphering the Role of Structural Dynamics in the Substrate 
Selectivity of AGMEs 
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Chapter 1 
The Aminoglycoside Acetyltransferase-(3)-IIIb Utilizes a Flexible 
Loop to Accomplish a Broad Substrate Profile 
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Abstract 
 
Much experimental data revealing the global thermodynamic properties and kinetic 
parameters of antibiotic and cofactor association with the aminoglycoside acetyltransferase-(3)-
IIIb have been described and discussed in Part I.  However, interpretation of experimental results 
is limited in the absence of a crystal structure.  Crystallization of this protein in various 
complexes for x-ray analysis is currently underway where initial crystals were confirmed to be 
protein and conditions are being optimized.  Meanwhile, a homology model has been generated 
from other aminoglycoside acetyltransferases.  These belong to a superfamily of 
acetyltransferases that despite little to no sequence homology, maintain a strikingly similar 
structural fold giving confidence that the model is likely to be close to the real structure of AAC-
(3)-IIIb.  This structure reveals a large loop that is the putative aminoglycoside binding site.  We 
postulate that this loop, being naturally flexible, accommodates the large number of structurally 
diverse antibiotics observed in experiments.  Furthermore, data obtained from nuclear magnetic 
resonance support the hypothesis of flexible motif(s) in the protein.   
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Section A: 
Family Origins and Homology Modeling 
The amino acid sequence of the aminoglycoside acetyltransferase-(3)-IIIb (AAC) was 
submitted to several homology modeling servers available online via Expasy protein databank 
(http://ca.expasy.org/tools) including EsyPred3D (1), SWISS-MODEL (2-4), and Geno3d (5).  
All yielded two proteins, Yokd and AAC(3)  from Bacillus (PDB ID: 2NYG and 3IJW,  
respectively) as the top  hits. Each resulting model was further energy minimized and analyzed 
with Molecular Operating Environment (MOE) software  (6).  From these, that of the SWISS-
MODEL, which used Yokd (chain A) as the template, had the least phi/psi angle outliers (ten) 
and steric clashes (eleven), all of which are situated in loop regions or at the termini, and 
contained all residues except the first 3 of the N-terminus and the last 6 of the C-terminus.  
Therefore, this model is used to aid in interpretation and discussion of some experimental data 
(figure 12). 
To our knowledge, all aminoglycoside acetyltransferases studied to date fall into the 
GNAT (GCN5-like acetyltransferase) superfamily.  Proteins in this superfamily share a highly 
conserved structural fold despite sequence identities as low as 3% (2, 7). This GNAT “core” 
structure is characterized by a 6-7 stranded, mixed polarity -sheet and four conserved motifs; A, 
B, C, D.  Motif A is responsible for coenzyme binding while motif B maintains a large loop 
region tentatively assigned to binding to the acetyl acceptor.  It is thought that motif B is the 
source for the high structural homology yet diverse acetyl transfer functionality within the 
GNAT superfamily (7).   
BLAST (8) searches of the AAC sequence did not yield hits to any known GNAT 
protein.  Instead, strong primary structure identity matches arise with other AAC-type proteins in  
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Figure 12:  Homology Model of AAC.  CoASH is shown in yellow sticks and is positioned 
from the superpositioning of the AAC homology model to the X-ray crystal structure of AAC(3) 
from Bacillus (PDB ID: 3IJW) co-crystallized with CoASH.  The GNAT conserved motifs A and 
B are shown in blue and purple, respectively.   
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Pseudomonas aeruginosa suggesting potential gene duplication.  A variety of other bacteria also 
have proteins that share considerable identities and similarities to AAC.  Of these, AAC(3) from 
Bacillus anthracis and Yokd from Bacillus subtilis have available crystal structures in the protein 
data bank (PDB ID: 3IJW and 2NYG, respectively).  COBALT sequence alignments (9) reveal 
that these two proteins share >53% sequence identity and >72% overall similarity to each other.  
Their crystal structures are also strikingly similar.  When aligned with AAC, all three share 
~20% identity with ~62% similarity in primary structure.  The sequence alignment from BLAST 
(8) of AAC (Query) with Yokd (Sbjct) is shown below where conserved residues are shown with 
letters in the middle row and further residue similarities shown as +. 
 
 
 
The presence of a six stranded, mixed polarity -sheet indicates that AAC maintains the 
GNAT core fold.  Of the four conserved GNAT motifs, only A and B could be distinguished and 
each of these motifs incorporates one strand into the central -sheet.  Figure 12 shows the 
homology model with motifs A and B highlighted in blue and purple, respectively, and the 
approximate position of coenzyme A as derived from superpositioning of the AAC(3) crystal 
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structure from Bacillus that was co-crystallized with CoASH.  These motifs are in homologous 
structural positions to other GNAT proteins although the central -strands of GNAT proteins that 
are side by side in the sheet are also in direct N to C terminal amino acid order.  However, 
juxtaposed -strands in AAC as well as AAC(3) and Yokd from Bacillus do not follow the 
primary sequence.  Reasons for this are unclear at present.  
 At the time of writing this dissertation, AAC in its apo- and various ligand-bound forms 
are undergoing crystallographic screening.  Thus far, a few conditions have yielded crystals 
which are small but diffract in a protein, and not salt-like, manner (Figure 13).  
 
Section B: 
Experimental Data Suggests a Flexible Region(s) 
 In the homology model of AAC, the secondary structure is made up of 23% -helices, 
14% -strands, 9.1% turns, and 54% random coils.  Circular dichroism experiments, analyzed  
via CDPro software (10), provide general support for this with 8.3% -helix, 32.7% -strand, 
21% turn, and 38% random coil content (Norris and Serpersu, unpublished data).  The most 
striking consistency between CD experiments and the model is the amount of random coils and 
turns where the totals from both methods are roughly 60%.  Such inherent flexibility may be 
responsible for AAC’s ability to bind a number of aminoglycosides with varying structures.   
 Such conclusions are consistent with the experimentally-detected dynamic properties of 
the enzyme in nuclear magnetic resonance (NMR) studies where 230 μM of uniformly labeled 
15
N AAC in 100 mM NaCl, 50 mM Tris-HCl, pH 7.6 at 25°C was titrated with 1-3 μL 
increments from concentrated stocks of CoASH (see Part I, Chapter 2, Section B for more 
experimental details).  Recall from these experiments that binding of coenzyme A alone occurred  
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Figure 13: Examples of protein crystals of AAC-(3)-IIIb. 
Panel (A) contains crystals of apo-AAC.  Panel (B) contains crystals of the AAC-Neomycin B 
complex.  Panel (C) shows crystals of the AAC-Paromomycin complex.  
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100 µm 
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with two apparent binding sites of distinguishable affinities from one another.  This revealed 
interesting dynamic properties of AAC.  First, during saturation of the first site, several peaks 
show a steady shift without broadening indicating these amides are in fast exchange between 
theligand-bound and apo-form of the enzyme (resonance 3 of Figure 14).  Several other peaks, 
on the other hand, show that they are in slow exchange as judged by the intensity of the peaks for 
the apo- and ligand-bound enzyme being proportional to the saturation level. Finally, further 
addition of CoASH beyond the saturation of the high affinity site caused some additional peaks 
to appear in the spectrum indicating that these amides were in an intermediary exchange regime 
in both apo-AAC and AAC–CoASH complexes and became visible only when the second 
CoASH binding site is occupied.  These observations clearly demonstrate the highly dynamic 
nature of regions of AAC and show that all three exchange regimes-fast, intermediary, and slow- 
conserved motif B is one candidate for a structural region affected by substrate interactions with 
AAC.  This would coincide with the experimentally observed increase in antibiotic affinity 
produced by coenzyme A. 
The postulated flexible loop also offers explanation for the size dependency of antibiotic 
stoichiometry as mentioned in Part I, Chapter 1.  Here, the gate-like loop appears to be able to 
cover a deep cleft in the putative antibiotic binding pocket.  Examination of the structure and 
manual docking of neomycin into this pocket shows residues with negatively charged side chains 
in reasonable positions to interact with amine groups of the antibiotic. These interactions would 
place the N-3 amine at a position proximal to the likely position of the acetyl moiety of acetyl 
coenzyme A based upon the homologous position of CoASH in crystal structures of both the 
Yokd and AAC (3) proteins from Bacillus (PDB entries 2NYG and 3IJW, respectively). 
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Figure 14:  NMR Detection of CoASH Binding to AAC.  (A) An expanded region of the 
1
H-
15
NHSQC spectrum of AAC in which three resonances demonstrate different behavior in 
response to CoASH binding.  Peak positions for 230 μM apo–AAC and 160 μM, 320 μM, and 
960 μM CoASH additions are shown in overlaid spectra in red, green, blue, and purple, 
respectively.  (B) The 
1
H spectrum of peak 1 from (A) demonstrates the slow (or borderline are 
observable with one bound ligand.  The proposed antibiotic binding loop of the GNAT-between 
slow and intermediary) exchange of this backbone amide between the free and CoASH-bound 
conformations. Apo-AAC (a), 160 μM (b), 320 μM (c), and 960 μM (d) CoASH.  The vertical 
dashed line is given for positional reference. 
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Moreover, this proposed orientation of neomycin would allow an amine of ring D to 
attract a carboxyl side chain of the motif B loop, pulling it down over the active site and thus 
blocking any other antibiotics from entering. Manual modeling of kanamycin A into the active 
site shows similar interactions for the orientation of N-3. However, kanamycin A has only three 
rings, and the third ring does not appear to be able to interact as favorably with the gating loop. 
Because loops are often the most dynamic of all secondary structural elements, it is possible that 
this weaker antibiotic-loop association would leave the antibiotic site more exposed, thus 
allowing smaller aminoglycosides to bind more than one molecule at a time. It is possible that 
smaller aminoglycosides with relatively weak affinity for the enzyme may bind to the larger 
binding site in multiple orientations, leaving room for another to bind in some cases, which may 
explain the stoichiometry of 1.5 determined with kanamycin B and tobramycin. In this analysis, 
we used the experimentally determined, enzyme-bound conformation of kanamycin (11) which 
shares a common conformational motif with a number of aminoglycoside antibiotics (including 
neomycin) bound to several different AGMEs (11, 12-15).  
 
Section C: 
Conclusions 
Taken together, these data suggest that AAC-(3)-IIIb is a member of the GNAT 
superfamily.   The homology model and crystal structures of Yokd and AAC(3) from Bacillus 
may also represent a unique branch of the GNAT family fold.  This model has aided data 
interpretation in the absence of a crystal structure which is a work in progress.  The postulated 
antibiotic binding loop is likely flexible enough to permit multiple binding stoichiometries for 
small sized antibiotics such as kanamycin A and tobramycin.  This loop may be one of the 
regions undergoing changes in motion/dynamics as a result of coenzyme A binding.  The fact 
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that CoASH creates an increase in antibiotic affinity as well as a perfect 1/1 antibiotic to AAC 
stoichiometry also points to a CoASH induced structural change in AAC. 
The dynamic behavior tentatively linked to the motif B loop may be the key for AAC’s 
substrate promiscuity. In this respect, AAC is like APH(3′)-IIIa, which also has a very broad 
substrate specificity and is an unusually flexible molecule in solution such that the apo form of 
this 31 kDa enzyme can exchange all of the amide protons in solution (26). This phenomenon 
will be discussed in much detail in the next chapter.  Thus, the flexibility of AGMEs may be a 
general property and the main cause of their substrate promiscuity.   
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Chapter 2 
Distal and Local Binding Site Motions Create Ideal Conditions for 
Association of Diverse Substrates with the Aminoglycoside 
Phosphotransferase-(3′)-IIIa 
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Abstract 
 
In this work, hydrogen deuterium exchange detected by NMR spectroscopy is used to 
determine the dynamic properties of the aminoglycoside phosphotransferase 3′-IIIa (APH), a 
protein of intense interest due to its involvement in conferring antibiotic resistance to both gram 
negative and gram positive microorganisms.  This represents the first characterization of 
dynamic properties of an aminoglycoside modifying enzyme.  Herein we describe in vitro 
dynamics of apo, binary, and ternary complexes of APH with kanamycin A, neomycin B, and 
metal–nucleotide. Regions of APH in different complexes that are superimposable in crystal 
structures show remarkably different dynamic behavior. A complete exchange of backbone 
amides is observed within the first 15 hours of exposure to D2O in the apo form of this 31 kDa 
protein.  Binding of aminoglycosides to the enzyme induces significant protection against 
exchange and ~30% of the amides remain unexchanged up to 95 hours after exposure to D2O.  
Our data also indicate that neomycin creates greater solvent protection and overall enhanced 
structural stability to APH than kanamycin.  Surprisingly, nucleotide binding to the enzyme–
aminoglycoside complex increases solvent accessibility of a number of amides and is 
responsible for destabilization of a nearby β-sheet thus providing a rational explanation for 
previously observed global thermodynamic parameters.  Our data also provide a molecular basis 
for broad substrate selectivity of APH.   
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Section A:  
Introduction 
Aminoglycoside modifying enzymes are employed by various gram negative and gram 
positive pathogenic bacteria for the purpose of detoxifying aminoglycoside antibiotics.  This 
class of antibiotics is among several in clinical use that have significantly lost their effectiveness 
in recent decades due to the presence of bacterial proteins capable of catalyzing a drug 
modifying event.  Many of these have been shown to be highly promiscuous (1-4).  The 
aminoglycoside phosphotransferase (3')-IIIa (APH) is one such enzyme (5, 6) found in 
Enterococcal and Staphylococcal bacterial strains (7) that can detoxify more than 10 different 
aminoglycosides of various size and structure by transferring a phosphate group from ATP to the 
3' and/or 5'' hydroxyl group (8).  Such modifications greatly decrease the antibiotic’s affinity for 
the 30S ribosome where it normally would bind and prevent proper protein translation in the 
bacterium leading to cell death.  Because of its broad substrate selectivity, APH has been 
extensively studied by kinetic and thermodynamic means as a model for aminoglycoside 
modifying enzymes and other proteins with large ligand repertoires (6, 8-13).  Crystal structures 
of APH in various binary and ternary complexes have also been solved in recent years (14, 15).  
A wealth of global information about APH and its target interactions has been gleaned from 
these studies, however, the molecular basis of substrate promiscuity and selection patterns of 
APH or any other aminoglycoside modifying enzyme remains unknown.  In this work, we report 
the first analysis of dynamic behavior of an aminoglycoside modifying enzyme and provide a 
site specific look into the intricacies of antibiotic and nucleotide binding.  Our data highlight 
remarkable differences between the global dynamic properties of the apo– and the ligand–bound 
forms of the enzyme and also reveal the structural consequences of antibiotic and nucleotide 
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binding in a residue specific manner.  Moreover, our results provide an explanation for the 
significant differences observed in the global thermodynamic parameters of complexes of 
enzyme with aminoglycosides in the absence and the presence of metal–ATP and reveal regions 
of the enzyme that contribute to these differences. 
 
Section B:  
Experimental Procedures 
Chemicals.  99.9% deuterium oxide and 99% 
15
N enriched salts were purchased from Cambridge 
Isotope Laboratories (Andover, MA).  Dithiothreitol (DTT) was acquired from Inalco Spa 
(Milano, Italy) while aminoglycosides and all other chemicals were obtained in the highest 
possible purity from Sigma-Aldrich.   
 
Enzyme purification.  APH was isolated from cells grown in 
15
N-enriched minimal media and 
purified as described earlier (5, 6). Triple- labeled APH ( 
15
N,
13
C,
2
H-APH) was isolated from 
cells grown in minimal media using 
13
C,
2
H-Glucose and  
15
N-salts.  10mM DTT was maintained 
at all times to keep the enzyme in a monomeric state due to the well-known tendency of this 
protein to dimerize via disulfide bond formation (5) which alters its substrate binding properties 
(10).  
 
Nuclear Magnetic Resonance.  NMR samples used in resonance assignments contained 250 μM 
15
N,
13
C,
2
H- APH and 300 μM tobramycin in 50 mM HEPES and 50 mM NaCl, pH 7.5.  Three-
dimensional HNCA, HNCACB spectra were acquired on a 900 MHz Varian spectrometer in the 
Complex Carbohydrate Research Center of the University of Georgia.  HNCO, HNCOCA, 
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HNCOCCH, and 
15
N-
1
H HSQC spectra were acquired with a 600 MHz Varian spectrometer at 
the University of Tennessee.  A table of partial assignments and the 
1
H-
15
N HSQC spectrum used 
in assignments is provided in the supplemental material but are now published at > 80% in 
Biomol. NMR Assign., (2009) 4 (1), 9-12.  We note that several missing assignments do not 
affect the conclusions of this work. 
 In HD exchange experiments, APH was present at 250 μM concentration in 50 mM 
HEPES and 50 mM NaCl, pH 7.5.  Where applicable, concentrations of kanamycin A, neomycin 
B (henceforth will be referred simply as kanamycin and neomycin, respectively), AMPPCP, and 
MgCl2 used were 300 μM, 350 μM, 500 μM, and 1000 μM, respectively, ensuring > 91% 
binding site saturation as calculated from previously determined dissociation constants (6, 16).  
HD exchange was followed by successive acquisition of 
15
N-
1
H correlation spectra in samples 
immediately after dissolving them in D2O.  Initial experiments indicated that a large number of 
amides may be exchanging very rapidly. Therefore, two sets of spectra were acquired with 
matched samples. SOFAST HMQC (17) experiments were employed to acquire more frequent 
data points at early stages of the exchange while sensitivity enhanced 
15
N-
1
H HSQC (18) with 
TROSY option (19) was acquired to collect data up to 95 hours of exchange.  HSQC experiments 
yielded spectra with better resolution compared to SOFAST HMQC.   Excellent agreement 
between the two sets of data acquired for all complexes confirmed validity and reproducibility of 
the observed HD exchange patterns. 
SOFAST experiments were optimized to a tip angle of 120 degrees (8.4 µs) and a delay 
of 300 ms between the scans while HSQC data was collected with 1s delays.  Experiments in 
H2O were conducted with 48-64 transients of 2048 real data points and 80 t1 increments in the 
nitrogen dimension.  For D2O exchange, it was necessary to collect spectra quickly with as little 
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resolution sacrifice as possible.  To this end, 16 scans were collected for 2048 real data points 
while second dimension increments were decreased to 48.  Spectral widths were held at 8012 Hz 
and 2500 Hz for the 
1
H and 
15
N dimensions, respectively.  A series of spectra were acquired after 
hydration of lyophilized samples in D2O at various time intervals up to 7 hours in SOFAST 
HMQC and up to 95 hours in HSQC experiments.  The time between the dissolution of 
lyophilized samples in D2O and the start of the data acquisition varied between 3 and 3.5 
minutes.  All experiments were performed at 27
◦
C to optimize the quantity of observable peaks 
with the stability of the protein.  For a few samples, a HSQC spectrum was taken in H2O before 
and after D2O exchange to ensure structural integrity of the lyophilized enzyme with and without 
ligands.  In addition, no loss of enzymatic activity was observed during the experimental process.   
All data were processed in identical fashion with nmrPipe software (20)  where a sin 
window function was applied in both dimensions and the left half of the proton spectrum was 
taken.  For the 
15
N dimension, spectra were zero filled to 256 points.  No baseline correction or 
other cosmetic procedures were applied.  Data were analyzed with Sparky (T. D. Goddard and D. 
G. Kneller, SPARKY 3, University of California, San Francisco) at matching contour levels.  
Protein structures were displayed with YASARA (21) software.  
 Rates of hydrogen exchange were calculated from the exponential decay of peak intensity 
versus time plots for individual residues and corrected for temperature and neighbor 
blocking/inducing effects as described elsewhere (22-24).  Briefly, protection factors were 
calculated as P = krc/kobs where krc is the corrected rate of exchange calculated for the amino acid 
in a random coil (completely exposed to solvent) from model peptides (22, 24) and kobs is the 
observed rate of exchange derived from exponential peak intensity decay curves.  ∆Gex values  
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Table 5:  Protection Factors and Free Energies of Exchange 
 
 APH-Kanamycin APH-Neomycin 
Residue P (x10
3
) ∆Gex (kcal/mol) P (x10
3
) ∆Gex (kcal/mol) 
Gly 213 80.6 ± 16.2 6.73 ± 1.35 166 ± 28.7 7.16 ± 1.24 
Ile 6 48.9 ± 4.29 6.44 ± 0.56 Unexchanged Unexchanged 
Ile 247 9.10 ± 2.38 5.43 ± 1.43 14.5 ± 5.59 5.71 ± 2.20 
Leu 13 9.62 ± 0.38 5.47 ± 0.22 24.6 ±14.4 6.03 ± 3.52 
Asn 87 373 ± 49.6 7.65 ± 1.02 204 ± 10.1 7.29 ± 0.36 
Phe 122 9.23 ± 1.35 5.44 ± 0.79 9.79 ± 4.60 5.48 ± 2.58 
Leu 10 3.48 ± 0.38 4.86 ± 0.53 7.59 ± 3.78 5.33 ± 2.65 
     
 APH-Kan-Ternary APH-Neo-Ternary 
Residue P (x10
3
) ∆Gex (kcal/mol) P (x10
3
) ∆Gex (kcal/mol) 
Ile 247 6.90 ± 0.96 5.27 ± 0.73 23.5 ± 13.9 6.00 ± 3.55 
Leu 13 8.43 ± 1.78 5.39 ± 1.14 25.0 ± 1.03 6.04 ± 0.25 
Phe 122 29.7 ± 7.23 6.14 ± 1.50 25.4 ± 7.07 6.05 ± 1.68 
 
 
 
 
Protection factors (P) and free energies of exchange (ΔGex) values for residues that are in the 
intermediary exchange regime and shared between the complexes.   See materials and methods 
for calculation details.  Reported errors are from exponential decay curve fitting. 
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were determined from the relationship, ∆Gex = -RT ln Kex, where Kex = kobs /krc.  A list of 
calculated protection factors and derived thermodynamic parameters are listed in Table 5.  Upon 
data analysis, it was discovered that the earlier time points collected by SOFAST contained only 
slightly more peaks than the first HSQC HD spectrum further emphasizing the incredible 
dynamic behavior of this enzyme.  For simplicity, the text will refer to all data as HSQC 
henceforth.   
 
Section C: Results 
Part 1: Apo– and Holo–APH 
As reported earlier (16), and as shown in Figure 15A, the  HSQCH2O spectrum of APH in 
the absence of any ligands shows an extensively overlapped pattern of cross peaks indicating a 
small range of differing chemical environments for each backbone amide.  This suggests that the 
apo–enzyme may adopt multiple conformations with intermediate interconversion rates that 
would drastically broaden the signals. In either case, this provides an inherent flexibility that is 
likely the property utilized for broad aminoglycoside promiscuity.  Hydrogen-deuterium 
exchange studies reveal that after only 15 minutes of exposure to D2O, less than 20% of all 
backbone amide resonances remain in the spectrum.  These peaks gradually decrease in intensity 
until all are completely dissipated to noise level at 15 hours (Figure 16A). 
In the presence of the MgATP analog, MgAMPPCP, the HSQCH2O spectrum has very 
little peak dispersion reminiscent of apo–APH (Figure 15B).  However, upon close inspection, 
the nucleotide bound form actually has a lesser distribution of isolated, distinguishable 
resonances although approximately 5% of the backbone amide groups remain protected from 
solvent up to 95 hours of exposure to D2O (Figure 16B).  Identities of these few resonances are  
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Figure 15: 
1
H-
15
N HSQCH2O spectra for ligand-free and ligand-bound forms of APH. A) 
apo–APH; B) APH–MgAMPPCP; C) APH–Kanamycin and D) APH–Kanamycin–MgAMPPCP.  
All are at matching contour levels. 
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Figure 16: HD exchange in apo-APH and various APH–ligand complexes detected by 1H-
15
N HSQCD2O experiments. A) apo–APH at t = 900 min; B) APH–MgAMPPCP at t = 3195 
min; C) APH–Neomycin at t = 3195 min; and D) APH–Neomycin–MgAMPPCP at t = 3195 
min.  All are at matching contour levels.  Differential exchange patterns between binary and 
ternary APH-neomycin observed in the spectra of panels C and D are similar for kanamycin 
bound complexes of APH. 
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not known because, unlike enzyme–aminoglycoside complexes, the overlap observed in HSQC 
spectra of the apo–APH and enzyme–MgAMPPCP render these spectra unsuitable for resonance 
assignments of a protein of this size. Chemical shift mapping experiments were also unsuccessful 
to allow assignments from the enzyme–tobramycin complex to be carried over to these spectra.  
 
Section C: Results 
Part 2: Antibiotic Binding 
When APH is in a binary complex with antibiotic, the HSQCH2O spectrum undergoes a 
dramatic alteration relative to that for the apo–protein (Figure 15C) (11).  Although there are 
antibiotic-dependent differences in all cases, about 85% of all non-proline resonances move to 
well isolated positions with proton chemical shifts between 6 and 11 ppm in the binary APH–
aminoglycoside complexes while the majority of those in the apo-enzyme range from only ~7.5-
8.8 ppm.  This indicates that APH adopts a well-defined structure upon binding of 
aminoglycosides.   
Because of the broad substrate selectivity demonstrated by APH, it was of interest to 
determine specific residues affected by binding to two structurally diverse aminoglycosides.  To 
this end, HSQCH2O spectra were acquired for the APH–kanamycin and APH–neomycin 
complexes where it was observed that more than 40 residues display significantly different cross-
peak positions.  Several of these are illustrated in Figure 17.  Furthermore, HD exchange data 
revealed at least 20 backbone amides with much greater solvent protection for neomycin bound 
APH relative to kanamycin (Figure 17, green colored residues).  Only one of the residues (Arg 
226) with chemical shift and solvent protection differences are within 4.5Å of the bound 
aminoglycoside while the rest are scattered in positions distal to the antibiotic binding site (>8Å).   
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Figure 17:  Residues differentially affected by binding of kanamycin and neomycin to APH.  
Residues with differentially altered chemical shifts and solvent accessibility are illustrated in 
yellow and green, respectively.  Neomycin is shown in purple and ADP in orange for reference.  
Protein data bank identification number 2B0Q. 
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The phenomenon of a large number of amides with chemical shift differences between 
complexes of enzyme with aminoglycosides is not limited to structurally different 
aminoglycosides but were also observed between complexes of structurally very similar 
aminoglycosides such as kanamycin A and kanamycin B (data not shown). These observations 
clearly indicate that effects of ligand binding to APH on structural and dynamic properties of this 
enzyme are not limited to changes in the active site only and are different for each ligand.  
 
Section C: Results 
Part 3: APH–Nucleotide–Antibiotic Complexes 
HD exchange patterns in APH–kanamycin–MgAMPPCP and APH–neomycin–
MgAMPPCP complexes, which represent APH with all bound substrates, were also determined.  
For simplicity, these complexes will be referred to as ternary forms of the enzyme henceforth.  
When the HSQC spectrum of binary APH–kanamycin is compared to that of its ternary, it 
becomes apparent that ~30 cross-peaks present in the binary complex are absent in the ternary 
complex.  This is attributable to line broadening from intermediary chemical exchange rates of 
these resonances.  Amino acids to which these resonances belong are situated in and around the 
nucleotide binding site (Figure 18).  Complementary to these results, HD exchange shows a 
dramatic increase in solvent accessibility of >20 un-broadened residues in the presence of 
nucleotide (Figure 16C, D).  Again, the vast majority of these are situated near the APH–
nucleotide interface.  
For the APH–neomycin ternary complex, only 5 residues demonstrate line broadening 
(Figure 17-green).  These five are common among both ternary complexes studied and include 
Ala 93, Lys 44, Leu 33, Val 20 and one residue yet to be assigned firmly.  Moreover, only 10 un- 
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Figure 18:  Residues with line broadening upon addition of MgAMPPCP to the APH–
aminoglycoside complex.  Shown in yellow are those found only when kanamycin is the 
antibiotic substrate while green amino acids are common to both kanamycin and neomycin APH 
complexes.  Neomycin is shown in purple and ADP in orange for reference.  Protein data bank 
identification number 2B0Q. 
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broadened residues display a significant enhancement in HD exchange upon the formation of the 
neomycin ternary complex as compared to more than 20 observed with kanamycin.  Tyr 42, Met 
45, and Thr 46 are among those residues that undergo a dramatic increase in HD exchange in the 
neomycin ternary complex.  Interestingly, these three are listed with those broadened (missing) 
resonances due to nucleotide binding to the APH-kanamycin complex.  Note that Lys 44, whose 
peak is missing in both ternary complexes, is a sequential neighbor whose side chain is shown to 
make direct contact with the nucleotide (14) .  All of these residues are of exceptional 
significance because their amide protons are involved in inter-strand hydrogen bonds of the five 
stranded, anti-parallel β–sheet located at the nucleotide binding interface (14, 15).   
Val 57 and Glu 60 also show increased HD exchange in the neomycin ternary complex 
while these are line broadened in the kanamycin ternary.  These residues are located within an α–
helix nearby to the β–sheet discussed above.  It has been shown that Glu 60 forms a stabilizing 
electrostatic interaction with Lys 44 that allows the lysine to be more stable for nucleotide  
coordination in the active site (14).  According to the crystal structure, one face of this α–helix 
makes extensive hydrophobic interactions with two strands of the β–sheet.  Taken together, these 
data suggest that many of the hydrogen bonds involved in formation of the β–sheet and α–helix 
are either weakened or broken as a result of nucleotide binding and may help explain the large 
difference in previously observed global thermodynamic parameters of binary versus ternary 
complexes as will be discussed in a later section. 
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Section C: Results 
Part 4: Rates of Exchange  
HD exchange patterns of amides are broadly divided into three categories determined by 
the length of time in which the amide peak remains in the spectrum after D2O exposure: Fast 
exchange (≤3-4 min), intermediary exchange (4 min to 36 hrs), and slow exchange (≥ 36 hrs).  
The criteria for slow exchange are based on the observation that little change occurs in the 
spectrum beyond 36 hours regardless of complex.  An intermediary exchange minimum of 4 
minutes is selected because this is the experimental dead time prior to acquisition of the first 
NMR spectrum (see materials and methods). 
Quantitative HD exchange rates of only a few backbone amides were determined because 
1) a great number (≥ 60%) of amide protons exchanged before the first spectrum could be 
acquired (are in fast exchange); 2) the slowest exchanging residues, accounting for 20-30% of 
resonances depending upon the APH complex in question, did not display a measurable decrease 
in intensity within the time frame of the experiments (~95 hrs), and 3) a number of the remaining 
resonances were either in overlapping regions or their intensity was too weak for accurate 
integration.  Thus, depending upon the complex, between 9 and 18 residues out of an initial ~250 
had calculable exchange rates and only a few of these are common among the complexes 
studied.  Exchange rates and derived thermodynamic parameters of the backbone amides that are 
shared between various enzyme–ligand complexes are listed in Table 5.  We emphasize that 
conclusions presented in this text are not dependent upon the quantitative analysis of these 
residues but rather on the unique behavior of various amino acids in different complexes that 
highlight differential dynamics of APH-ligand interactions. 
 
 101 
 
 
Section D: Discussion 
Part 1: Apo–APH has an Unusually Dynamic Backbone  
In the absence of ligands, the HSQC spectrum of APH shows significant resonance 
overlap with the vast majority of peaks situated between ~7.5 and 8.8 ppm in the 
1
H dimension 
(11).  This is common for denatured or partially unfolded proteins (25-27).  Data acquired with 
circular dichroism spectroscopy (unpublished, Ozen and Serpersu) and the crystal structure (14)  
show that extensive secondary structure exists in apo–APH.  From this, it is plausible that the 
apo-enzyme is natively in a conformational state where the secondary structure has formed but 
hydrophobic interactions that aid in tertiary structure are weak.  As a result, APH is likely to be 
highly flexible; sampling several conformational states thus creating broadened and overlapped 
amide resonances.  Intuitively, this will produce a highly dynamic and potentially unstable 
overall protein structure.  To test these hypotheses, NMR hydrogen-deuterium exchange 
experiments were conducted to qualitatively determine the dynamics of APH in the absence of 
ligand.  Under our experimental conditions, over 80% of the backbone amide protons are 
exchanged for deuterium within 15 minutes of exposure to D2O and after only 15 hours, every 
amide hydrogen exchanges. Observation of a complete exchange of backbone protons of a 31 
kDa protein in native form within such a time frame is quite rare.  To our knowledge, there are 
no other examples of complete exchange except in cases of protein unfolding as seen for the apo-
Src SH3 domain (28). Such rapid and extensive exchange is indicative of a highly dynamic 
protein structure where hydrophobic cores and hydrogen bonds involved in secondary structure 
may be transient.  We believe this to be one of the main reasons why this enzyme is so 
promiscuous in substrate selection and able to bind structurally diverse aminoglycosides with 
similarly favorable thermodynamic parameters (6, 11).   A significant number of other proteins  
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have been found to naturally exist in an intrinsically unfolded form and are induced to a defined 
structure upon ligand binding (29, 30).  The inherent flexibility associated with such proteins is 
often a property utilized for broad substrate selectivity.   
Crystallographic studies (14, 15) report that the structure of APH is largely unaffected by 
substrate binding with the exception of the nucleotide and antibiotic positioning loops. 
Superpositioning the backbone of APH in several complexes yields RMSD values between 0.68 
Å and 1.10 Å with the smallest deviation between APH–nucleotide and APH–nucleotide–
kanamycin complexes while the largest is observed between apo-enzyme and enzyme–nucleotide 
complexes. However, the NMR data presented in this work demonstrate that dynamic and 
structural features of the apo-enzyme and aminoglycoside-bound forms are significantly different 
in solution. The apo-enzyme and the enzyme–nucleotide complex appear to have a distribution 
of interconverting conformations while APH–aminoglycoside complexes display a well-defined 
structure. In addition, more than 15% of the cross-peak positions of residues throughout the 
protein can differ significantly between different enzyme–aminoglycoside complexes depending 
upon the antibiotic bound thereby further highlighting the dynamic nature of this protein.   
 
Section D: Discussion 
Part 2: Neomycin Stimulates Greater Backbone Solvent Protection and Stability than 
Kanamycin 
For binary and ternary complexes of both kanamycin and neomycin, it is observed that at 
least 60% of the residues become solvent exchanged during the experimental dead time. 
However, the backbone amide protons of several amino acids are significantly less accessible to 
solvent (in slow exchange) when neomycin is the substrate but exchange fast when kanamycin is 
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the bound ligand.  Only one of these residues is in proximity to the antibiotic (Arg 226) while the 
rest are in distal regions (Figure 17). This is similar to observations made with the AKAP 
binding protein (31).   
What stabilizing interactions are present for the APH–neomycin complex that are absent 
for APH–kanamycin?  We note that these two antibiotics differ in structure and spatial 
orientation.  For neomycin, the 2-deoxystreptamine (DOS) ring common to all aminoglycosides 
is 4,5-disubstituted and contains four rings while kanamycin is 4,6-disubstituted and has only 
three rings as illustrated in Figure 19.  An overlay of enzyme-bound conformations (32) of these 
two aminoglycosides is also shown in Figure 19.  The APH–neomycin–MgADP and APH– 
kanamycin–MgADP crystal structures (15) reveal that the amino acids with decreased solvent 
accessibility due to neomycin, in both binary and ternary complexes, are located in two regions 
of the protein.  The first contains residues on the antibiotic binding domain in the region nearest 
the D ring of neomycin.  This part of the protein maintains extensive hydrophobic interactions 
between several α-helical moieties.   Several residues that have significantly different chemical 
shifts between kanamycin and neomycin HSQCH2O spectra are also situated in this area (Figure 
17).  From the crystal structure, it is evident that only one interaction exists in this region 
between neomycin and APH that is not possible for kanamycin.  Specifically, the hydroxyl at C3 
of neomycin’s D ring forms a hydrogen bond with Glu 231.  This in itself may not suffice as an 
explanation for our data; however, because of the close association of the helical side chains, it is 
possible that this hydrogen bond could be the initiation of a chain of events leading to the 
observed ligand specific differences in this area.  
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Figure 19:  Structures of kanamycin A (panel A, top) and neomycin B (panel A, bottom).  A 
3D overlay of enzyme bound conformations (panel B) demonstrates the differences in spatial 
orientation of the two aminoglycosides bound to APH where blue is neomycin and red is 
kanamycin.  
 
 
 
 
 
A B D ring 
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The rest of the residues which significantly differ in HD exchange behavior between the 
kanamycin– and neomycin–bound forms of the enzyme are located in the anti-parallel β-sheet 
and the nearby α-helix located on the nucleotide binding domain.  In the absence of nucleotide, 
Lys 44, Met 45, Thr 46, Glu 60 and Trp 85 slowly exchange when neomycin is present but are in 
a fast exchange regime with kanamycin (Figure 20, right panel).  Of these, only Lys 44 displays 
broadening behavior for the neomycin bound ternary complex.  However, Lys 44, Met 45, Thr 
46 and Glu 60 are all broadened in the ternary complex with kanamycin.  This indicates that the 
non-covalent interactions of the enzyme to both nucleotide and antibiotic contribute to the 
stability of the β-sheet and its neighboring helix.  In other words, ATP binding induces some 
destabilizing effects (to be discussed in a later section) while neomycin propagates counteracting 
associations that kanamycin is not capable of.   
It is not straight forward to explain how neomycin causes such changes in solvent 
accessibility in this region.  However, we propose that an intricate series of interactions are 
induced by formation of a hydrogen bond between the 4′′′ hydroxyl of neomycin ring D with the 
carboxyl side chain of Asp 193 located on a nearby loop.  This stabilizes the loop which in turn 
allows for a subsequent hydrogen bond to take place between the side chains of Ser 194 (of the 
same loop as Asp 193) and Glu 24 situated on the nucleotide positioning loop.  In addition, the 
6′′′ amine of neomycin forms an electrostatic interaction with Glu 24.  Lys 30 is seated at the 
apex between the newly stabilized nucleotide positioning loop and one of the strands of the β-
sheet.  The backbone carboxyl group of Lys 30 forms an interchain hydrogen bond with the 
backbone amide of Met 45 in the β-sheet.  A schematic of these interactions is presented in  
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Figure 20:  Nucleotide binding site of APH. Left Panel:  Exchange broadened residues on the 
β-sheet of the APH–kanamycin ternary spectrum are shown in red.  Lysine 44 and tyrosine 42 
are shown with their side chain interactions with ADP (yellow).  Right Panel:  Amino acids with 
an increase in solvent accessibility due to nucleotide binding are shown in green amidst those 
that demonstrate line broadening in the APH–kanamycin ternary spectrum (red).  For clarity, 
only the hydrogen bonds relevant to the discussion are shown. 
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Figure 21.  Kanamycin, lacking a fourth ring and any similar contacts, is unable to facilitate such 
stabilizing propagation.   
Ligand induced transmission effects are not uncommon.  For example, an intricate 
network of hydrogen bonds through a series of water molecules was found through HD exchange 
to be responsible for heme oxygenase plasticity and propagating the effects of ferric azide and 
cyanide binding (33).  Similarly, α-helices and β-strands are stabilized by both direct and indirect 
ligand contact in dihydrofolate reductase complexes (34).  These interpretations reiterate the 
incredible complexity of protein–ligand interactions.  
 
Section D: Discussion 
Part 3: Binding of Nucleotide Increases Backbone Solvent Accessibility and Structural 
Flexibility of the Nucleotide Binding Region 
Direct comparison of the APH–kanamycin binary and ternary spectra reveals that 
approximately 30 cross-peaks found in the binary complex become exchange broadened and 
NMR undetectable when metal–nucleotide is added.  Not surprisingly, the residues belonging to 
those resonances are found to be concentrated around the nucleotide binding site (Figure 18).  
This is also the case when neomycin is the antibiotic although only 5 residues are missing from 
the ternary spectrum in this case.  The likely cause for this dramatic difference between the 
complexes formed in the presence of kanamycin and neomycin is an increase in structural 
stability found for neomycin bound APH as discussed earlier.   
One might argue that the missing resonances may have simply shifted underneath other 
peaks or into a crowded region.  However, there are 30 absent peaks in the kanamycin ternary 
spectrum while all other peaks have a corresponding binary resonance with no significant 
changes in chemical shifts.  Therefore, it is unlikely that so many resonances could all have  
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Figure 21:  Interactions that are involved in enhanced structural and dynamic stability of 
APH induced by neomycin binding.  Left Panel: Shown interactions of the 4′′′ hydroxyl and 6′′′ 
amine groups of ring D of neomycin with APH are exclusive to neomycin due to the absence of 
this ring in kanamycin.  Right Panel:  Nucleotide interactions with Lys 44 and Tyr 42 (shown in 
gray for clarity) counteracts some of the stabilization effects of neomycin binding. 
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become “hidden”.  A similar situation of broadening is found when subtilisin complexes with 
prodomain resulting in a loss of HSQC peaks (35). Several of the broadened peaks observed in 
the APH–ternary complexes belong to residues involved in the inter-strand hydrogen bonding 
network facilitating the formation and stability of a five stranded, anti-parallel β-sheet.  These 
include Val 20, Tyr 32, Lys 33, Tyr 42, Lys 44, Met 45, and Thr 46 in the kanamycin ternary 
complex while only Val 20, Lys 33 and Lys 44 are broadened for neomycin ternary (figure 18).  
The side chains of Lys 44 and Tyr 42 from the β-sheet directly interact with nucleotide via a salt 
bridge/hydrogen bond and a π-π ring stacking interaction, respectively (14, 36, 37).  Moreover, 
Val 57 and Glu 60, located on the nearby α-helix, are broadened in the kanamycin ternary 
complex and not in neomycin ternary.  Glu 60 forms an electrostatic interaction with Lys 44 on 
the β-sheet.  This helps position the Lys 44 side chain for contact with the phosphate groups of 
the incoming nucleotide.  It appears then, that nucleotide binding causes a disruption or 
weakening of the natural hydrogen bonding between the some of the backbone amide protons 
and their carbonyl partners.  Therefore, it is likely that association of the side chains of Lys 44 
and Tyr 42 with nucleotide causes the sheet to stretch or buckle at the areas of contact 
subsequently weakening their inter-strand hydrogen bonds (Figure 20).  While other examples of 
increases in exchange upon ligand binding exist in literature (34, 38), the molecular bases for 
such phenomena have not been discussed.  
Further evidence of a β-sheet destabilization comes from evaluation of the HD exchange 
data for APH–antibiotic complexes in the absence and presence of MgAMPPCP.    Of the 
residues in the β-sheet that have analyzable peaks in both binary and ternary spectra for 
kanamycin bound APH, several are characterized by slow exchange (strong protection from 
solvent) in the absence of nucleotide and then move into a fast exchange regime when 
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MgAMPPCP is present.  Included in this category are Leu 43, Met 90 and Ser 91.  From the right 
panel of figure 20 it is clear that these residues (green) are each within the regions of the amino 
acids with nucleotide induced resonance broadening (red) and with the exception of Ser 91 are 
hydrogen bond partners with each other.  
In the neomycin ternary complex, many of the residues that are exchange broadened in 
the kanamycin ternary complex, including Tyr 42, Met 45, Thr 46 and Glu 60, are in slow 
exchange in neomycin binary but quickly exchange with solvent in the presence of nucleotide.  
This emphasizes the conclusion that neomycin induces greater protein stability than kanamycin 
and that nucleotide binding counteracts some of these effects. 
The increased solvent accessibility and change in sheet stabilization becomes even more 
significant when the side chain blocking effect is considered.  Bai and Englander (39) 
demonstrated that amino acids in β-sheets having long side chains can protect the backbone from 
solvent resulting in an increase in the strength of the inter-strand hydrogen bonds.  This is 
relevant to APH in that the side chains of the β-sheet that point toward the solvent where 
nucleotide interacts include leucines, methionines, tyrosines and lysines (Figure 20). The 
opposite side of the β-sheet is protected from solvent by hydrophobic interactions with the N-
terminal α-helix. From this it could be postulated that in the absence of nucleotide, solvent 
protection of the β-sheet amino acids occurs via side chain blocking, with a greater protection 
with neomycin than kanamycin as previously discussed.  When nucleotide binds, water 
molecules associated with the incoming nucleotide and/or at the binding interface may be 
trapped creating an environment where the inter–strand hydrogen bonds are weakened by being 
forced into interactions with solvent.  This is supported by the fact that several of the residues 
undergoing exchange broadening in the presence of nucleotide are either in a slow or 
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intermediary HD exchange regime in its absence as mentioned previously.  One alternative 
explanation is that nucleotide interaction with Tyr 42 and Lys 44 causes the β-sheet to stretch or 
buckle at the point of contact thus exposing the backbone amide groups of nearby residues to 
solvent and increasing the chances for an exchange event. 
It is also suggested from the crystal structure that the backbone amide hydrogen of Ala 
93, situated on a loop nearby to the β-sheet, is directly involved in binding and stabilization of 
the adenine ring of ATP (14).   Intuitively, this proton will be more protected from solvent in the 
presence of nucleotide.  In both the APH–kanamycin and APH–neomycin binary complexes, Ala 
93 quickly exchanges within 4 minutes of D2O exposure as expected.  However, this residue is 
among those amino acids with broadened resonances in both ternary complexes of APH 
confirming the formation of a hydrogen bond with nucleotide. 
Overall, an increase in solvent accessibility is observed for the nucleotide bound APH–
antibiotic complexes.  The vast majority of amino acids displaying this property are restricted to 
the nucleotide binding site.  Furthermore, a significantly smaller number of residues have 
calculable exchange rates in ternary complexes when compared to binary.  While our dynamic 
data can be interpreted with the visual aid of the crystal structures, the observed ligand induced 
differences are not readily visible in the structures themselves.  When the β-sheet from crystal 
structures of apo- and ligand-bound APH is superimposed, RMSD values between 0.21 Å and 
0.56 Å are observed.  An example is shown in Figure 22 as an overlay of the binary APH–
nucleotide with the ternary APH–nucleotide–kanamycin complexes.  
Our data also provide rationale for the significant differences observed between the 
global thermodynamic parameters of binary and ternary complexes where the formation of 
ternary complexes were accompanied by significantly less negative enthalpy (by more than 15  
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Figure 22. Comparison of the β-sheet region from superimposed crystal structures.  Front  
(left) and side (right) view of superimposed crystal structures of APH–MgAMPPNP (14) (yellow 
with red nucleotide) and APH–MgADP–kanamycin (15) (blue with cyan nucleotide) at the 
nucleotide binding region.  Amino acids that are either broadened or show altered HD exchange 
patterns upon addition of nucleotide to the enzyme–aminoglycoside complex are shown in 
purple.  Carbonyl oxygens are hidden in the right panel for clarity.  
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kcal/mol) than binary complexes (6), which was compensated by a more favorable entropy 
yielding similar ΔG values for both types of complexes. From results described in this paper, it is 
possible to attribute the less negative ∆H of the ternary complex, at least in part, to the 
weakening/breaking of the hydrogen bonds of the β-sheet and the neighboring α-helix. The 
resulting decrease in stability of the β-sheet and its immediate surroundings may contribute to the 
observed increase in entropy.  Release of some solvent molecules upon binding of nucleotide 
may also contribute to increased entropy observed for the formation of ternary complexes.  
Osmotic stress experiments to determine the extent of solvent release upon binding were 
unsuccessful because of the tendency of this protein to interact differentially with varying 
osmolytes thus providing inconclusive data. 
 
Section E: Conclusions 
In this work, we described APH–ligand interactions in an amino acid specific manner in 
analysis of dynamic properties of an aminoglycoside modifying enzyme for the first time.   Here 
we provide further evidence for an inherently very flexible apo–enzyme as the means for broad 
substrate promiscuity.  Our data show that antibiotic binding alters dynamic properties of the 
enzyme and induces a well-defined protein structure in an antibiotic dependent manner.  
Specifically, neomycin increases the dynamic and structural stability of APH relative to 
kanamycin.  This complements our previous observation of dramatic differences between 
complexes of kanamycins and neomycins with APH regarding solvent effects as well as in heat 
capacity (ΔCp) (11). In that work, we attributed the very large decrement in the heat capacity to 
conformational changes in the protein which are now supported by HD exchange data.  
Furthermore, nucleotide interaction with APH does not appear to significantly alter APH 
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structure but in fact increases solvent accessibility at the nucleotide binding site and weakens 
inter-strand hydrogen bonds in the nearby β-sheet and α-helix.   
Our data support the hypothesis that APH is designed to recognize aminoglycosides and 
it is the non-covalent interactions of APH with antibiotic and not nucleotide that are required to 
induce a stable and well-defined enzyme structure in solution.  It is plausible that this is one of 
the evolutionary means by which APH is geared to respond to the ever changing flux of 
aminoglycoside antibiotics.  These properties, in conjunction with a high concentration of 
negatively charged side chains in the active site that is similar to RNA, the natural 
aminoglycoside target, allow APH to detoxify a large number of structurally diverse 
aminoglycoside antibiotics.  Overall, our results aid in understanding detailed protein–ligand 
associations for APH that may be applied to other aminoglycoside modifying enzymes and/or 
highly promiscuous proteins in general. 
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Conclusions 
 Two prokaryotic proteins, the aminoglycoside acetyltransferase-(3)-IIIb (AAC) and the 
aminoglycoside phosphotransferase-(3′)-IIIa (APH) are among a family of proteins that modify 
aminoglycoside-type antibiotics and thus prevents these drugs from performing their bactericidal 
effects.  Understanding protein-drug interactions of aminoglycoside modifying enzymes 
(AGMEs) will have clinical significance as aminoglycosides are often used to fight serious 
bacterial infections such as meningitis and tuberculosis.  However, these drugs are losing their 
efficacy in a vast array of bacterial species due mainly to the more than forty different AGMEs 
that have been identified.  AGMEs must bind to a cofactor to catalyze antibiotic modification 
and are classified based on the moiety that is transferred from the cofactor to the aminoglycoside.  
Three such transfer activities have been identified and include nucleotide 
(nucleotidyltransferase), phosphate (phosphotransferase), and acetyl (acetyltransferase) 
modifications that are covalently attached to various functional groups on the antibiotic.  
 Outside of clinical interest, the AGME-antibiotic system is one that provides unique 
insights into the field of protein-ligand interactions in general.  Many of these proteins have been 
identified to interact with a number of different aminoglycoside antibiotics that can range widely 
in structure.  As our general knowledge of proteins continues to fill textbooks with fascinating 
structure-function relationships, mechanisms of promiscuity are gaining much attention as this is 
an increasingly common trait in many protein systems.  Furthermore, experiments to determine 
the nature and degree of fluctuations in protein structure in the presence and absence of ligands, 
often referred to as “dynamics”, are vital to a complete understanding of protein-substrate 
interactions and will be of intense need in drug design which has traditionally relied solely on 
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protein crystal structures that provide a part, but not all, of the information required to most 
efficiently combat disease. 
 Prior to work presented in this dissertation, very little was known about the 
aminoglycoside acetyltransferase-(3)-IIIb (AAC).  This protein not only represents the 
acetyltransferase family but is also of interest because it modifies the N-3 amine group that is a 
component of all typical aminoglycoside antibiotics.  AAC shows measurable catalytic activity 
with a number of antibiotics in both the kanamycin and neomycin structural families of 
aminoglycosides where all have low micromolar affinities but neomycins are turned over slower 
than kanamycins.  Similar to other AGMEs, substrate inhibition is observed but appears to be 
size specific as only smaller or more structurally constrained antibiotics could slow catalysis 
rates at high concentrations.  This coincides with binding stoichiometries derived from 
isothermal titration calorimetry experiments from which aminoglycosides with less than 4 rings 
show an N value between 1.5 and 2.0 while those with 4 or more are always 1.0.  However, when 
antibiotic binding is measured to a preformed complex of AAC and CoASH, stoichiometry is 1.0 
with every antibiotic.  From this it is hypothesized that CoASH may cause a conformational 
change in the antibiotic site of AAC that allows for optimal binding of antibiotics.  Moreover, 
CoASH increases antibiotic affinity to AAC up to 20 fold from which its binding is accompanied 
by a significantly more favorable enthalpy (optimal antibiotic binding = higher affinity = more 
bonds formed = more negative ΔH) and less favorable entropy (tighter antibiotic binding = 
restriction of motional freedom = more negative TΔS).  These also speak for a CoASH enforced 
structural rearrangement designed for antibiotic association.  However, in the case of APH, the 
opposite trend was observed in which the presence of ATP causes a less favorable enthalpy and 
more favorable entropy of antibiotic binding.  For APH, NMR experiments showed that this was 
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due, at least in part, to a nucleotide induced hydrogen bond breakage in a β-sheet.  Crystal 
structures are not yet available for AAC from which to derive detailed explanations for the 
observed results.  However, preliminary screening has yielded protein-diffracting crystals of 
AAC in various complexes.   
The homology model of AAC shows that a large loop, a conserved motif among the 
GNAT superfamily of acetyltransferases, may be flexible and as such potentially promotes 1) the 
large, diverse substrate profile of AAC, 2) dynamic behavior of many 
1
H-
15
N correlation peaks 
as observed in NMR experiments upon CoASH titration, 3) accommodation of multiple 
stoichiometries for smaller antibiotics, and 4) easy induction of necessary structural changes for 
productive binding and catalysis of antibiotics by CoASH.  Taken together, these strongly 
suggest that AAC has motifs that are dynamic in nature.  For APH, NMR data demonstrated an 
apo structure sampling multiple conformations that upon ligand binding becomes dominated by a 
single, well-defined conformation.  APH and AAC do not share any sequence identity or 
structural similarity to each other, and yet they can modify many of the same aminoglycosides 
albeit at different positions.  While APH is fluid in the apo-state such that its overall structure is 
affected by ligand binding and hence facilitates interaction with a diverse substrate repertoire, 
data suggest that AAC is utilizing a large loop at the aminoglycoside binding site that is 
manipulated by CoASH for the most ideal antibiotic binding.  It is therefore hypothesized that 
flexibility is a general property of AGMEs that facilitates their common promiscuity and that the 
two distinct mechanisms described here may be found in other protein systems in which diverse 
substrate profiles have been observed.  
 While the work presented in this dissertation has provided much knowledge about the 
properties of AAC and APH, more information will be required to gain a full understanding of 
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these systems for the edification of both the public health and the world of protein-ligand 
interactions.  Such studies will include but not be limited to 1) role of solvent in protein-ligand 
interactions, 2) NMR detected relaxation dispersion experiments to help quantify and 
characterize the various protein conformations being experienced by AAC and APH, 3) amino 
acid specific labeling of AAC for simplification and partial assignment of 
15
N-
1
H correlation 
NMR peaks, 4) obtainment of x-ray crystal structures of AAC in its unbound and various ligand 
bound complexes, and 5) product isolation for determination of substrate binding order and 
kinetic analysis.   
 At the culmination of these researches, it is evident that this is not an end of a dissertation 
but instead a commencement of an in-depth understanding of the complexities of protein science.  
It is a path consisting of twists and turns from which one cannot often see around the next bend; 
but the scientist, in his never ending curiosity to uncover and understand the intricacies that have 
been created to allow life to exist and flourish, will inevitably follow.  My feet have been placed 
upon this path.  May God continue to guide them. 
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